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STELLINGEN 
De hypothese van Pearl en Taylor dat het retrovirus protease actief is 
als dimeer valt moeilijk te rijmen met het proces van autokatalytische 
klieving waarmee dit protease zich vrij maakt. 
Pearl and Taylor (1987) Nature 329, 351-354. 
De genen voor de 2A en 3C eiwitten van poliovirus zijn ontstaan door 
duplicatie van een enkel protease gen. 
Dit proefschrift. 
3. Het onderzoek aan proteases van poliovirus en cowpeamozaïek virus toont 
aan dat de evolutie van virusonderzoek ten minste zo interessant is als 
de evolutie van virussen. 
Franssen et al. (1984) J. Virol. 50, 183-190. 
Toyoda et al. (1986) Ceil 45, 761-770. 
Vos (1987) Proefschrift LU Wageningen. 
Uit. de homologie in aminozuurvolgorden tussen het 250 kilodalton eiwit 
van beet necrotic yellow vein virus en het nsPl eiwit van sindbisvirus 
kan geconcludeerd worden dat de furovirussen behoren tot de supergroep 
van "sindbis-like" plantevirussen. 
Goldbach (1987) Microbiological Sciences 4, 197-202. 
Hoewel het tot nu toe niet gelukt is een door het cowpea mozaïek virus 
M-RNA gecodeerd 58 kilodalton eiwit te detecteren in met cowpea mozaïek 
virus geïnfecteerde planten, wordt dit eiwit waarschijnlijk wel door 
het virus geproduceerd. 
Dit proefschrift. 
De eiwitten die Flore bij gekoppelde in vitro transcriptie en translatie 
van het sonchus yellow net virus na 22 uur incubatie in een tar-
wekiemextract gedetecteerd heeft, zijn het gevolg van een bacteriële 
en/of schimmelinfectie. 
Flore (1986) Proefschrift LU Wageningen. 
7. Het toenemend aantal aanwijzingen dat recombinatie een belangrijk 
mechanisme is in de evolutie van virussen pleit voor het vermijden van 
het gebruik van termen als soort, geslacht en familie in de taxonomie 
van virussen. 
UOCfSt 
I. Kleren maken niet de mens. 
9. De Olympische Spelen dienen in het vervolg onder de naam Wereldspelen 
georganiseerd te worden. 
10. Wetenschappelijke doorbraken op medisch gebied hebben niet vanzelf-
sprekend een positieve invloed op het welzijn van de mens. 
11. Toerisme leidt tot culturele armoe. 
Stellingen behorend bij het proefschrift: 
"Polyprotein processing in the expression of the cowpea mosaic virus 
genome". 
13 november 1987 Joan Wellink 
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CHAPTER 1 
SCOPE OF THE INVESTIGATION 
Cowpea mosaic virus (CPMV) is a plant virus with a genome consisting of two 
positive strand RNAs which are separately encapsidated in icosahedral particles 
denoted Bottom (B) component and Middle (M) component. While both particles (or 
RNAs) are necessary to infect plants, B component RNA (B-RNA) is able to repl i -
cate independently in isolated cowpea protoplasts. Both RNAs contain a small 
protein (VPg) at their 5' end and have a poly(A) ta i l at their 3' end. Sequence 
studies have revealed that each RNA contains a single long open reading frame, 
strongly supporting the concept that the RNAs are translated into so-called 
polyproteins that are subsequently cleaved into several functional proteins. 
This polyprotein processing takes an important position in the expression of the 
CPMV RNAs because the production of proteins involved in replication of the 
viral RNAs and virus assembly is regulated by this process. 
Several other groups of RNA viruses e.g. the animal picorna- and alphaviruses 
and, as was more recently shown, the plant poty- and nepoviruses use a strategy 
for gene expression similar to that of CPMV. A common feature of these viruses 
is that they encode the enzyme(s) for the proteolytic activity involved in the 
specific processing of the polyproteins. In chapter 2 different groups of viru-
ses and their specific proteases are reviewed. 
In chapters 3, 4, 5 and 6 of this thesis the processing of the CPMV polyproteins 
is studied. Chapter 3 describes the determination of the proteolytic cleavage 
si tes in the B-RNA-encoded 200K polyprotein. This was established by partial 
sequencing of isolated cleavage products. 
It was shown that the B-RNA-encoded 24K protein is a protease, able to cleave at 
specific sites by expressing cDNA clones, containing both M-RNA and B-RNA-
specific sequences, in Escherichia coli (Chapter 5). Furthermore, by employing 
antibodies raised against a synthetic peptide of 25 residues i t was shown that 
this protease is found in infected cells both as intermediate cleavage products 
(170K, 110K, 84K) and as a final cleavage product (24K) (Chapter 4). 
A study on the expression of M-RNA in vivo is described in chapter 6. The detec-
tion of the M-RNA-encoded 48K protein and 60K precursor to both capsid proteins 
in infected protoplasts definitely proves that, similar as has been observed in 
vitro, M-RNA is also in vivo expressed via proteolytic processing of a polypro-
tein (Chapter 6). 
Finally we have localized viral proteins in an infected cell by staining 
ultrathin sections of CPMV infected protoplasts with specific antibodies and 
gold-labeled protein A. It was found that the electron-dense material, which is 
a major cytophatic structure induced in a cell by a CPMV infection, contains 
viral non-structural proteins (Chapter 7). 
CHAPTER 2 
PROTEASES INVOLVED IN THE PROCESSING OF VIRAL POLYPROTEINS 
Joan Wellink and Ab van Kammen 
Department of Molecular Biology, Agricultural University, 
De Dreijen 11, 6703 BC Wageningen, The Netherlands 
Archives of Virology, in press 
1. INTRODUCTION 
Various RNA viruses express their genomic RNA by synthesis of a high molecular weight 
polyprotein which is post-translationally cleaved by proteases into functional viral gene 
products. This mode of gene expression has f i rs t been demonstrated for poliovirus (69), but 
has then been found with several other animal viruses as well as plant viruses. 
The proteases catalyzing the specific cleavages of a polyprotein can either be encoded by 
the virus or occur in the host prior to infection. As pointed out by Rice and Strauss (55) 
there is a clear difference in the location in the cell of polyproteins cleaved by virus-
encoded and host-encoded proteases. Polyproteins that reside in the cytoplasm are cleaved 
by virus-encoded proteases. These polyproteins are usually primary translation products. On 
the other hand viral glycoproteins which occur associated with membranes are cleaved by 
host proteases during maturation and/or transport. 
In this review we will focus on the processing of cytoplasmic polyproteins catalyzed by 
virus-encoded proteases. Some viruses which encode protease(s) for polyprotein processing 
use in addition host proteases for the processing of their structural (glyco)proteins. This 
is for example the case with alphaviruses and flaviviruses (see sections 2.2. and 2.3.). 
Cleavage of polyproteins by virus-encoded proteases into several active polypeptides has 
sofar only been found with some RNA viruses and not with DNA viruses. Some DNA viruses 
like adenovirus and bacteriophage T4 use proteases in the maturation of their capsid 
structures, but these proteases fall outside the scope of our review since in their case i t 
is a question of releasing a single mature protein from i t s precursor. By definition these 
precursors are not considered polyproteins. 
In the following section we shall describe different groups of viruses for which 
polyprotein processing by virus encoded proteases has been studied in some detail. For 
each virus group the current model for the expression of the genetic information will be 
presented. Some details will be given about the identification and characterization of the 
protease(s) such as sensitivity to certain protease inhibitors and the cleavage s i tes 
recognized by the protease(s). Some viruses for which processing by a virus-encoded 
protease has not yet firmly been established, but is very likely to occur, will also be 
described briefly. Finally the different virus-encoded proteases and their specificities will 
be compared with each other and with cellular proteases, and the cleavage si tes recognized 
by these proteases will be discussed. We conclude the review by discussing possible 
mechanisms used by viruses to regulate this processing. 
2 . VIRUSES USING VIRUS-ENCODED PROTEASES IN THE EXPRESSION OF THEIR GENOMES 
2;1. Retroviruses 
Retroviruses contain a positive strand RNA of mol.wt. 3.2 x 106 which is replicated via DNA 
Intermediates by the action of a virus-encoded reverse transcriptase. The retrovirus 
genome contains three regions which encode proteins as i l lustrated in Fig. 1 with the 
genetic map of moloney murine leukemia virus (Mo-MuLV) RNA. The gag region encodes a 
polyprotein that is cleaved to generate four structural proteins, the pol region encodes 
the reverse transcriptase and the eny region glycoproteins found at the surface of the 
virion. The genomes of some other retroviruses possess additional genes. The gag 
polyprotein is cleaved by a virus-encoded protease that can be expressed in rather 
different ways. Rous sarcoma virus (RSV) and related retroviruses have a fifth gag protein, 
pl5. Actually the first virus-encoded protease that was purified and characterized has 
been the pl5 protein. It was isolated from virus particles and identified as the protease 
able to cleave in vitro the gag polyprotein Pr76SaS synthesized by translation of RSV RNA 
in a cell-free system of ascites cells (76). Through the use of several inhibitors, the P15 
protease of avian myeloblastosis virus (AMV), a retrovirus related to RSV, was characterized 
as a cysteine protease showing papain like activity (14). This protease was purified and 
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shown to cleave Pr76 g a g and the readthrough translation product Pr l80 g a g _ p o *, obtained by 
immunoprecipitation from infected cells, into defined viral proteins. The protease was not 
able to cleave the env precursor protein (45). The cleavages in the env polyprotein are 
probably achieved by a host protease during transport to the surface membrane of the 
infected cell (63). When the nucleotide sequence of RSV was determined, the cleavage s i tes 
in the gag polyprotein could be identified by sequencing the amino (N)-termini and carboxy 
(C)-termini of the gag proteins (pl9-pl0-p27-pl2-p!5). This revealed that small peptides 
were removed between pl9 and plO, and p27 and pl2 and that cleavages occurred between 
different amino acid pairs (Tyr His, Gly Ser, Met Pro, Met Ser, Met Ala, Ser Leu, and Leu 
Thr). No homology was present between the sequences surrounding the cleavage si tes 
(cleavage occurs between the amino acid residues on positions -1 and +1), but on positions 
-2, -3 , and -4 only amino acids with an aliphatic group (Pro, Ala, Val, Leu, He) were found 
(61, 63). 
For retroviruses related to the murine (Mo-MulV) retroviruses the protease is not one of 
the gag proteins but is rather a part of the pol region produced after readthrough of the 
gag termination codon (Fig. 1) (83). In the Mo-Mulv gag precursor protein some homology 
around the cleavage sites is apparent, e.g. -4 Ser/Thr, -2 Ala/Leu, -1 Tyr/Leu and +1 
Pro/Ala/Thr (65, 84). Homology around the cleavage sites also exists between different 
viruses in this group and some proteases are able to cleave the gag polyprotein of 
several other viruses (84, 85). 
A third group of retroviruses encode their proteases in a reading frame independent of 
both the gag and pol regions e.g. human T cell leukemia virus 1 (HTLVI) and bovine 
leukemia virus (BLV) (62). The BLV protease has been purified and sequenced and based on 
this information i t was proposed that this protease was expressed via a frameshift 
suppression of the gag termination codon (85). 
Although the proteases of retroviruses can be expressed in different ways, their relative 
position in the viral genomes is similar and they show considerable sequence homology with 
each other. One of these conserved regions shows homology with the active si te of acid 
proteases like pepsin (62, 71; see section 3). Furthermore, the processing of the gag 
polyprotein seems to be identical in all retroviruses. 
I t remains to be seen how the active retrovirus protease is generated from i t s precursor. 
Autocatalysis or an init ial cleavage by a cellular enzyme may be involved. 
2.2. Alphaviruses 
Alphaviruses are enveloped viruses with a plus strand RNA genome of mol. wt. 4.3 x 106. 
The RNA is capped and contains a poly (A) tail at its 3' end. The genome of several 
alphaviruses has been sequenced (67, 70). Genomic RNA is translated into a high molecular 
weight protein which is the precursor of the four non-structural proteins. During an 
infection a subgenomic RNA is produced which is translated into a polyprotein from which 
structural 
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Fig. 2. Genetic map of SV RNA. SFV RNA does not code for a stop codon between nsP3 and 
nsP4. The structural proteins are translated from a subgenomic messenger (not shown). C is 
the capsid protein, El, E2 and E3 are the envelope glycoproteins. For explanation of the 
symbols see legend to Fig. 1. 
the structural proteins are released (see Fig. 2). Since processing of the alphavirus 
polyproteins has recently been reviewed by Strauss et al. (68), only a short summary will 
be presented here. Sindbis virus (SV) RNA and middelburg virus (MV) RNA are translated into 
two polyproteins, the larger being the result of readthrough of an opal termination codon 
located behind nsP3 (66). Thus the nsP4 protein is produced in lower amounts compared to 
the other proteins (42). The sequence of semliki forest virus (SFV) RNA does not contain a 
stopcodon a t a similar position (70), but cells infected with SFV yet contain nsP4 in lower 
amounts than the other proteins, due presumably to a shorter half life of the nsP4 protein 
(36; see section 4). The nsP4 protein shows sequence homology with proteins implicated in 
RNA replication (1, 35), but i t is not known why the amount of this protein has to be 
regulated in this way. 
The cleavage sites in the polyproteins of several alphaviruses have been established by 
sequencing the cleavage products. A clear consensus is found for these sites, -3 
Val/Ile/Ala, -2 Gly, -1 Ala/Gly/Cys, +1 Ala/Gly/Tyr (68). In vitro, the cleavages are 
inhibited by ZnCl2 and TPCK (chymotrypsin inhibitor) and insensitive to PMSF (serine 
protease inhibitor) and TLCK (trypsin inhibitor) but this does not determine which type of 
protease is involved (12). One of the non-structural proteins probably is the virus-encoded 
protease. By using ein in vitro transcription translation system, evidence has been obtained 
that nsP2 is involved in the processing (E. Strauss, VII International Congress of Virology, 
Edmonton, August 1987). 
The structural proteins probably are translated from a subgenomic RNA as a polyprotein 
(see Fig. 2). The capsid protein located a t the N-terminus of the polyprotein is released 
by an autoprotease activity of the capsid protein. This was f i rs t postulated on the basis 
of in vitro translation experiments (2) and further evidence was obtained from sequence 
studies of temperature sensitive mutants defective in cleaving the capsid protein from the 
polyprotein precursor. The mutants mapped into a region of the capsid protein that showed 
considerable homology with the active si te of serine proteases (27). Moreover this cleavage 
occurs behind a tryptophan residue which is characteristic of chymotrypsin-like serine 
proteases (68). The other structural proteins are thought to be released from their common 
precursor by host proteases such as signalases and golgi apparatus associated proteases 
(24. 55, 68). 
2.3. Flaviviruses 
Flaviviruses contain a single positive stranded RNA genome of mol. wt. 3.9 x 106. The RNA 
is capped and contains no poly (A) tail . Only after the complete nucleotide sequence of 
yellow fever virus (YFV) had been determined, revealing the presence of a single large 
open reading frame on the RNA, i t was established that the flavivirus-encoded proteins 
were produced upon processing of a single polyprotein (54). The present knowledge on 
processing of flaviviral proteins has recently been reviewed by Strauss et §1. (68). A model 
for the expression of flaviviral RNA is shown in Fig 3. Sequence data on the structural 
proteins and some non-structural proteins have revealed that the primary large-sized 
translation product is probably processed by both viral and host proteases (54, 68). 
Only limited data are available for the amino acid sequences of the non-structural 
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Fig. 3. Genetic map of YFV RNA. The non-structural proteins 2a, 2b, 4a and 4b have not yet 
been identified in infected cells. NSI is a glycosylated now-structural protein, with an 
unknown function, C is the capsid protein, M is a glycoprotein and E is the envelope 
glycoprotein. For explanation of the symbols see legend to Fig. 1. 
proteins of different flaviviruses (53) but a consistent set of amino acids is found a t 
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known and putative cleavage sites; -2 Lys/Arg, -1 Arg, -1 Gly/Ser/Thr/Ala. Most flavivirus 
proteins are associated with membranes (10), but the cleavages are carried out in the 
cytosol by a protease which is probably virus-encoded. Furthermore, i t was found that 
incubation of flavivirus infected cells with ZnCl2 or TPCK resulted in the accumulation of 
larger flavivirus specific proteins compared to control infections (11), indicating that the 
flavivirus protease probably is a serine protease. 
The organisation of the flavivirus structural proteins shows some similarity with the 
organisation of the alphavirus structural proteins, and probably in both cases the same 
type of proteases are used i.e. signalases and golgi apparatus associated proteases. The 
cleavages between the envelope glycoprotein E and glycoprotein NS1, and NS1 and NS2a are 
probably also carried out by signalases since these cleavage sites show homology to si tes 
cleaved by signalases (54, 68). The occurrence of a conserved Cys Trp amino acid pair, 
which is part of the active s i te of thiol proteases, in glycoprotein precursor prM 
sequences from several flaviviruses, suggests that prM may function as a protease in the 
cleavage of glycoprotein precursor prM to the M protein (13). This cleavage occurs after 
two basic residues and consequently i t has also been proposed that a trypsin-like golgi 
apparatus associated protease catalyses this cleavage (68). 
2.4. Picornaviruses 
The genome of picornaviruses consists of a single positive strand RNA molecule with a mol. 
wt. of about 2.5 x 106 with a small protein, VPg, covalently linked to the 5' end and a 
poly(A) ta i l at the 3' end. The proteolytic processing of the polyproteins encoded by these 
viruses has been reviewed by Palmenberg (56) and Nicklin et al. (52) and we refer to these 
reviews for additional information. The nucleotide sequence of the genome of various 
picornaviruses has been determined including members of each of the Picornavirus 
subgroups i.e. the enteroviruses, poliovirus (PV), coxsackievirus (COX), and hepatitis A virus 
(HAV), the human rhinoviruses, HRV2 and HRV14, the cardiovirus, encephalomyocarditis virus 
(EMCV) and the aphthovirus, foot and mouth disease virus (FMDV). The genomes of the 
picornaviruses have a similar organisation. As an example the genetic map of PV is shown 
in Fig. 4. The RNA contains a single open reading frame encoding for a large polyprotein 
which has been divided into three regions, PI (1ABCD), P2 (2ABC), and P3 (3ABCD) (see Fig. 
4) from which proteins are derived with similar functions in all picornaviruses. 
For PV the N-termini of most of the virus-encoded proteins found in infected cells have 
been sequenced and for some of these proteins the C-terminal ends as well. In this way i t 
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Fig. 4. Genetic map of PV RNA. The genome can be divided in three regions: PI (1ABCD), P2 
(2ABCD) and P3 (3ABCD). FMDV and EMCV RNA code for one additional protein (L) located at 
the 5' end. FMDV possesses three tandemly arranged VPgs and almost completely lacks the 
2A coding region. For explanation of the symbols see legend to Fig. 1. Pol = RNA 
polymerase. 
has been firmly established that the processing of the PV polyprotein happens by eight 
cleavages between Gin Gly amino acid pairs, one cleavage between ID and 2A between a Tyr 
Pro pair and one cleavage between 1A and IB between a Asn Ser pair (38; see Fig. 4). 
For FMDV cleavage sites in the polyprotein have also been determined by protein 
sequencing but the cleavage sites in the polyproteins of most of the other picornaviruses 
have been determined by computer-assisted alignment of sequences using the high degree of 
sequence homology shared by all the viruses. There are three types of cleavage sites in 
Picornavirus polyproteins. 
1. Most of the cleavages occur between Gin Gly pairs or between pairs of related amino 
acids like Gin Ser, Glu Ser or Glu Gly. 
2. The cleavage between 1A and IB occurs at Ala Asp or Asn Ser pairs. 
3. The cleavage between ID and 2A is different from the other two types for most of the 
picornaviruses. 
Three different proteolytic activities are involved in these cleavages, probably all virus-
encoded. 
Protein 3C is responsible for the f i rs t type of cleavage in all picornaviruses. In PV, 
protein 3C was identified as a protease by Hanecak et §1. (28) using a cell free extract of 
PV infected Hela cells and antibodies raised against protein 3C. The antibodies were able 
to inhibit al l cleavages at Gin Gly sites in the PV polyprotein produced in the extract, 
but not a t the Tyr Gly s i te between ID and 2A. Furthermore the part of the PV genome 
coding for the 3C protein and some of the flanking sequences were expressed in E. coli 
and i t was found that the 3C protein was active as a protease in E. coli cells capable öf 
removing the flanking sequences by cleavage at the normal Gin Gly sites (29). Introduction 
of an insertion in the 3C coding region abolished this activity, confirming that the 3C 
protein was responsible for the cleavages. Also for EMCV and FMDV, the 3C protein has been 
shown to possess proteolytic activity (8, 39, 58, 59). For several years i t was thought that 
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the Tyr Gly cleavage between ID and 2A in the PV polyprotein was achieved by a host-
encoded activity, but recently, following the same approach as described for PV 3C 
protease, Toyoda et al. (72) showed that the 2A protein is the protease responsible for 
this cleavage. 
The Asn Ser cleavage between 1A and IB is different from the previous two types. This 
cleavage is linked with the maturation of the virus particles and occurs upon completion 
of the assembly of the RNA and capsids into virions. For all picornaviruses this cleavage 
is probably an autocatalytic event mediated by a serine residue, located at the N-terminus 
of IB, and the RNA (5). All picornaviruses have the following pattern of processing. The 
f irst cleavage is between the PI and P2 regions i.e. between protein ID and 2A and 
happens in the nascent polyprotein chain. For several picornaviruses this cleavage is 
catalyzed by 2A but in the cardioviruses and aphthoviruses represented by EMCV and FMDV 
respectively this cleavage occurs between 2A and 2B and is mediated by a sofar unknown 
agent (33). The large majority of the remaining cleavages are catalyzed by protein 3C in 
all picornaviruses. The final cleavage occurs during maturation of the virion between 1A 
and IB and appears to be an autocatalytic reaction. 
There exists a considerable amount of amino acid homology between the picornaviral 3C 
proteases. Especially conserved are a histidine and cysteine residue in the C-terminal part 
of the proteins. These residues are possibly part of the active site of the protease (4). 
Furthermore Ivanoff et al. (32) have shown that the cysteine is essential since mutation of 
this cysteine to a serine residue abolished the proteolytic activity of PV 3C tested by 
expression of the corresponding sequence in E. coli. There also is some homology between 
the PV, HRV and COX 2A proteins and the 3C proteases, especially with regard to the 
sequence around the conserved cysteine residue (40; see section 3). This cysteine motive is 
not present in the HAV and EMCV 2A or 2B proteins and i t remains an open question if in 
these viruses 2A (or 2B) is a protease. 
All known cleavages carried out by the 3C proteases occur between Gin or Glu and Gly or 
Ser (and less frequently Thr/Ala/Met/Val) amino acid pairs. The surrounding sequences of 
these si tes do not show much homology. Only at position -4 there is usually (but not 
always) an amino acid with an aliphatic side chain (52): preferentially Ala in the case of 
PV and COX, Val/Ile/Ala in the case of HRV, Leu/Val/Ile in the case of HAV and Pro in the 
case of FMDV. For EMCV Phe or Leu are usually present at position -4, and for 8 out of 9 
si tes a Pro is found at position -2 or +2 (56, 57). The above described characteristics are 
usually not present around amino acid pairs that are not cleaved (see section 4). 
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2.5. Comovlruses 
Cowpea mosaic virus (CPMV), the type member of the comoviruses, is a plant virus with a 
bipartite positive stranded RNA genome of mol.wt. 2.2 x 106 (B RNA) and 1.2 x 106 (H RNA). 
Both RNAs have a VPg (3K) at their 5' ends and poly (A) ta i l at their 3' ends. 
The nucleotide sequences of B-RNA and M-RNA contain each a single large open reading 
frame (41, 74). Both RNAs are translated into large polyproteins, which are subsequently 
cleaved through a number of successive steps into functional proteins (Fig. 5). The 
cleavage sites in the primary translation products were established by determining partial 
N-terminal sequences of various virus specific proteins found in CPMV infected cells and 
locating the coding regions of these proteins on each of the CPMV RNAs. Cleavages were 
found to occur between Gin Ser, Gin Gly and Gin Met amino acid pairs (Fig. 5). The 
cleavage si tes have an Ala at position -4, and an Ala or Pro a t position -2, but further 
show l i t t l e amino acid homology (81). There are quite a number of Gin Ser, Gin Gly and Gin 
Met pairs in the polyprotein which are not cleaved, indicating that secondary and ter t iary 
structures are probably important in determining the sites used for proteolytic processing 
(see section 4). 
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Fig. 5. Genetic map of CPMV RNAs. All proteins indicated in the figure have been identified 
in infected cells, with the exception of the M-RNA-encoded 105K, 95K and 58K proteins 
which only have been observed upon in vitro translation of M-RNA. For explanation of the 
symbols see legend to Fig. 1 and 4. 
Results from in vitro translation studies with both CPMV RNAs suggested that two 
B-RNA-encoded proteins namely the 32K and 24K proteins were involved in the proteolytic 
processing of the CPMV polyproteins (19. 21, 60). The involvement of the 24K protein in the 
proteolytic processing was strongly supported by a strong amino acid sequence homology 
between the 24K protein and the picornaviral 3C proteases (20). Direct evidence that the 
B-RNA-encoded 24K polypeptide is the protease catalyzing the cleavages at the three types 
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Fig. 6. Schematic representation of transcripts derived from complete and mutagenized cDNA 
clones of CPMV B- and M-RNAs. The open reading frames are indicated by white bars and 
the non-coding sequences by single lines. The open reading frames derived from M-RNA are 
hatched. The construction of these mutants is described by Vos et al. (1987). The positions 
and sizes of the deletions are indicated above each RNA. The cleavage sites used to 
release the individual proteins from the polyprotein are indicated by symbols which are 
explained in the figure. 
15 
of sites in the polyproteins encoded by B- and M-RNA was obtained by experiments using 
cDNA clones of both M- and B-RNA placed downstream of the T7 or SP6 promoter. RNA, 
transcribed in vitro from these clones produced, upon in vitro translation in reticulocyte 
lysates, proteins which were faithfully processed into final cleavage products identical to 
the proteins translated from the viral RNAs (75, 79, 80). Starting with full-length clones, 
several deletion mutants were constructed as illustrated in Fig. 6. 
A deletion in the 24K coding region prevented proteolytic processing of the primary 
translation products completely, whereas deletions in other regions did not block 
proteolytic cleavages at the specific cleavage sites. This proves that the 24K protein, or 
proteins containing the 24K polypeptide, is able to catalyze all cleavages in the 
B-RNA-encoded polyprotein. It was also demonstrated that the 32K polypeptide previously 
thought to be a second B-RNA-encoded protease, did not have any protease activity. 
To determine whether the 24K protein was also responsible for the Gin Met and Gin Gly 
cleavages in the M-RNA-encoded polyproteins, hybrid DNA copies were constructed which 
contained in their open reading frame the coding sequence of the B-RNA-encoded 24K 
protein and the M-RNA-encoded capsid proteins including the Gin Met and Gin Gly cleavage 
si tes (Fig. 6). The results from in vitro translation experiments with transcripts from these 
hybrid clones demonstrated that the 24K protein was able to cleave at the Gin Met and Gin 
Gly sites occurring in the M-polyprotein part of the hybrid protein as well as the Gin Met 
and Gin Gly cleavage sites bordering the 24K sequence and occurring in the B-polyprotein 
part of the hybrid protein. The processing of the M-RNA-encoded polyproteins by the 24K 
protein is however more complicated than i t appeared. Processing of these polyproteins was 
also tested by adding the translation products from RNA transcripts of full-size B-cDNA 
and of the deletion mutants thereof. If translation products obtained with mutant B-cDNA 
lacking an Intact 32K polypeptide but having an intact 24K protein were added to 
M-RNA-encoded polyproteins no cleavage at the Gin Met site in the M-polypeptide occurred. 
Thus cleavage under native conditions requires not only the 24K protease but in addition 
an intact 32K protein. There is no specific proteolytic activity associated with the 32K 
polypeptide, but this protein is required as a cofactor or helper to achieve the Gin Met 
cleavage in the M-RNA-encoded polyprotein (79). 
2.6. Nepoviruses 
The genome of tobacco ringspot virus (TobRV), type member of the plant nepoviruses, 
consists of two species of plus strand RNA of mol. wt. 2.8 x 106 (RNA 1) and 1.3 x 
106 (RNA 2). Both RNAs contain a VPg (4K) at their 5' end and a poly (A) ta i l at their 3' 
end. In vitro TobRV RNA 1 is translated into a 207K protein which upon prolonged 
incubation in the presence of DTT is cleaved into 37K and 180K proteins whereupon the 
180K protein is further processed into 128K and 65K proteins (34). RNA 2 has been 
translated into a 116K protein, which was processed upon addition of the translation 
products of RNA2 into smaller products among which the viral coat protein (18, 34). From 
these experiments i t was concluded that RNA 1 coded for a protease able to cleave the 
RNA 2 translation product and probably also the RNA 1 products. A tentative model for the 
expression of the TobRV RNAs is shown in Fig. 7. 
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Fig. 7. Genetic map of TobRV RNAs. CP is the capsid protein. The dashed lines bordering the 
protease (pro) indicate that until now such a protein has not been identified. The presence 
of VPg, pro and pol in the TobRV 130K protein is based on TBRV RNA 1 sequence data (C. 
Fritsch, personal communication). For explanation of the symbols see legend to Fig. 1 and 4. 
Translation of the RNA 1 of another nepovirus, grapevine fanleaf virus (GFLV), resulted in 
220K, 195K and 190K proteins (49). In the presence of amino acid analogs only the 220K 
protein was synthesized. Purified RNA 2 could be translated into a 125K protein. Addition 
of RNA 1 and RNA 2 translation products resulted in processing of the 125K protein into a 
68K protein and the 58K coat protein. A 62K protein was also detected but i t s origin was 
not clear. 
Recently, the nucleotide sequence of the nepovirus tomato blackring virus (TBRV) RNA 2 was 
determined (44). The sequence contained one large open reading frame which could code for 
a 150K protein. This is in agreement with in vitro translation studies with RNA 2 in which 
a 160K protein was produced (22). The 160K protein could not be processed into smaller 
products, but antiserum against the coat protein recognized this protein (22). The coat 
protein was tentatively located a t the C-terminal part of the 150K protein and i s possibly 
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released from i ts precursor by cleavage at a Glu Ser or a Glu Thr site (Fig. 7; 44). This 
cleavage is probably catalyzed by a TBRV RNA 1 encoded protease similar to what has been 
observed for TobRV. The assumption of a protease encoded by RNA 1 is supported by recent 
sequence information obtained for TBRV RNA 1 (C. Fritsch, personal communication). A 
considerable amount of amino acid homology with the CPMV B-RNA-encoded 24K protease was 
found at a position in the TBRV RNA 1 sequence corresponding to the position of the 24K 
coding sequence on the CPMV B-RNA (Fig. 6) (C. Fritsch, personal communication, see section 
3). 
2.7. Potyviruses 
The potyvirus group is the largest among plant viruses and is characterized by rod shaped 
virions with a length of 720-800 nm. The genome of these viruses consists of plus strand 
RNA of mol. wt. 3,2 x 106. The RNA contains a VPg (6K) at the 5' end and a poly (A) ta i l a t 
the 3' end. In vitro translation of potyvirus RNA has usually resulted in a large set of 
proteins. Using antisera raised against several purified potyvirus proteins, and peptide 
mapping, a genetic map of the potyvirus genome has been constructed and i t was proposed 
that potyvirus proteins are produced by proteolytic processing of a polyprotein (17). By 
translating soybean mosaic virus RNA in the presence of N-formyl-(35S)methionyl 
-tRNAimet and amino acid analogs, additional evidence was obtained that polyproteins were 
produced (73). When translation of papaya ringspot virus (PRV) RNA was carried out without 
a reducing agent (DTT), a large protein (330K) was produced clearly showing that PRV RNA 
can be translated into a single large polyprotein which is subsequently processed (82). 
Using the hybrid arrested translation technique the genetic map of tobacco vein mottling 
virus (TVMV) RNA was further refined and some evidence was obtained for a proteolytic 
activity correlated with a defined region on the genetic map (31). Recently the complete 
nucleotide sequence of the RNAs of two potyviruses, tobacco etch virus (TEV) and TVMV 
were determined. It was found that the genome of both viruses contained a single large 
open reading frame (3, 15). 
Protein sequence information was only obtained for the capsid proteins while for TVMV i t 
was shown that the capsid protein was released from the C-terminal end of the polyprotein 
by cleavage at a Gin Ser site. Furthermore, by placing the genetic map on the protein 
sequence, i t was possible to propose the cleavage sites most probably used for the release 
of the other proteins from the polyprotein (see Fig. 8). Five of these si tes show a high 
degree of homology (-4 Val, -3 Arg/Lys, -2 Phe, -1 Gin, +1 Gly/Ser) (15). In TEV the capsid 
protein is also released by cleavage at a Gin Ser si te while other si tes have also been 
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tentatively identified. The five sites corresponding to those in TVMV showed a consensus 
(-6 Glu. -4 Ile/Val/Leu, -3 Tyr, -1 Gin, +1 Gly/Ser) (3). 
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Fig. 8. Genetic map of TVMV RNA. CP is the capsld protein, Nia and Nib are proteins that in 
the case of TEV form nuclear inclusions, CI forms the cytoplasmic inclusions and HC is the 
helper component involved in vector transmission. VPg has not yet been mapped on the TVMV 
genome and i t s position is based on the analogy with the picorna- and comoviruses and the 
presence of suitable cleavage si tes (see Fig. 4 and 5). For explanation of the symbols see 
legend to Fig. 1 and 4. 
Amino acid homology was detected between the Nib protein of TEV and TVMV and the CPMV 
87K protein involved in RNA replication and between the Nia protein and the CPMV 24K 
protease (3, 16). By in vitro translation of in vitro transcripts of TEV cDNA i t was shown 
that the Nia protein is the protease responsible for at least three cleavages in the 
polyprotein (9). Also some evidence has been obtained that the Nia protease is released 
from i t s precursor by autocatalytic cleavages. Furthermore, the proteolytic activity resided 
only in the C-terminal 25K region of the Nia protein (9). It appears likely that the 
potyvirus Nia protease cleaves at the 5 homologous cleavage sites. Probably a second viral 
protease, like the 2A protease in PV or a host-encoded protease is responsible for the 
other cleavages. There is some homology between the 42K protein of TEV and the 2A protein 
of PV suggesting that this 42K protein might be a second protease. On the other hand, such 
homology has not been found with the TVMV 42K protein (16). Therefore i t is possible that 
the homology of TEV 42K and PV 2A is fortuitous and i t seems premature to assume a 
protease function for the 42K protein. 
2.8. Tymoviruses 
Turnip yellow mosaic virus (TVMV), the type member of the tymoviruses, possesses a 
monopartite RNA genome of mol. wt. 2.106. The RNA contains a cap at i t s 5' end and a 
t-RNA-like structure at i ts 3' end (for a recent review see 30). The coat protein (20K) is 
translated from a subgenomic messenger corresponding to the 3' region of the genomic RNA. 
The genomic RNA is translated in vitro into 150K and 195K proteins, the 150K protein being 
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the result of a so-called "stop" signal which is probably not a normal termination codon 
(47). Translation into the 195K protein stops at a UAG codon which can be read through 
resulting in the production of a 210K protein which partially overlaps the coat protein 
gene coding region (47). Upon translation in different in vitro systems the 195K and 210K 
proteins are proteolytically cleaved into 120K and 78K and 93K proteins respectively 
whereas in each system the 150K protein was found to be a stable product (46, 48, 87). On 
the basis of these studies i t was proposed that the C-terminal part of the 195K protein 
encodes a proteolytic activity which cleaves the 195K polypeptide autocatalytically (48). 
Until now nothing is known about the sequence of this putative protease and the nature of 
the cleavage sites. 
2.9. Other plant viruses 
For some other plant viruses there is circumstantial evidence that they use proteolytic 
processing in their expression and that this activity is virus encoded. Turnip rosette 
virus (TRosV) contains a single RNA species of mol. wt. 1.4 x 106. The RNA contains a VPg 
(12K) linked to i t s 5' end. In vitro translation of this RNA resulted in four products with 
m.w. 105K, 67K, 35K and 30K (coat protein) and i t was shown that the 67K protein was 
probably a cleavage product of the 105K protein (50). The protease catalyzing this 
cleavage seems to be virus encoded and is of the thiol type, as deduced from the effect of 
the inhibitor N-ethylmaleimide on the processing (50). 
Pea enation mosaic virus (PEMV) contains two RNAs with positive polarity. The RNAs possess 
a VPg (17.5K) and no poly (A) tai l . In vitro, RNA 1 is translated into 147K, 88K and 36K 
proteins. Tryptic peptide comparisons reveal that the la t te r two proteins are related to 
the 147K protein. Furthermore i t has been shown that the 88K protein contains sequences 
related to the capsid protein. The capsid protein has a mol. wt. of 22K and therefore i t i s 
very likely that proteolytic processing in involved in the expression of this virus (23). 
This is probably also the case for the monopartite luteoviruses. The genomic RNA of potato 
leaf roll virus (PLRV) possesses a VPg (7K) and no poly (A). Translation of the RNA in vitro 
yields 71K and 125K proteins, but no capsid protein (24K) can be detected under these 
conditions (43). 
Recently the RNA 1 of beet necrotic yellow vein virus (BNYW), type member of the 
furoviruses, was sequenced to reveal one large open reading frame capable of coding for a 
protein of 240K (7). In vitro translation of this RNA yields 50K and 150K proteins and a 
small amount of a 200K protein (88). Probably these proteins are derived from a 240K 
precursor by proteolytic processing but there are no data available about the protease(s) 
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involved in this process. 
3. COMPARISON OF THE VIRAL PROTEASES WITH EACH OTHER AND WITH CELLULAR 
PROTEASES 
In this section we will discuss the implications of the amino acid homology between the 
different viral proteases on the one hand and between viral proteases and cellular 
proteases on the other hand (4, 16, 20, 26, 71). The cellular proteases can be divided into 
four main families, the serine-, cysteine-, acid- and metallo-proteases (51). 
Table 1. Famil ies of p r o t e o l y t i c enzymes. 
family characteristic active 
site residues* 
representative 
protease 
serine proteases I His (57), Asp (102), Ser (195) chymotrypsin 
serine proteases II Asp (32), His (64), Ser (221) subtilisin 
cysteine proteases Cys (25), Asp (158), His (159) papain 
acid proteases Asp (32), Asp (215) pepsin 
métallo proteases I Zn, Tyr (248), Glu (270) carboxypeptidase A 
métallo proteases II Zn, Glu (143), His (231) thermolysin 
*The numbers behind each residue correspond to the position in the amino 
acid sequence of the enzymes listed in column 3. 
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A representative example of each family is given in Table 1 (modified from 51), together 
with the amino acids constituting the active site. In the serine and métallo protease 
families two groups can be distinguished which have similar active si te configurations but 
bear no other structural or evolutionary relation to each other. They can therefore be 
considered examples of convergent evolution. At the other hand a protease with amino acid 
sequence homology and an active si te configuration similar to one of the six proteases 
shown in Table 1 is probably derived from a common ancestor protein. There are s t i l l other 
families of proteases for which the mechanism of action remains to be elucidated but i t 
seems likely that a peptide bond can be cleaved in only a few ways. The four families 
listed in Table 1 probably represent the most important mechanisms (51). 
The survey of virus-encoded proteases presented in the previous section leads us to 
distinguish three different groups. First there is a large group of Picornavirus 3C-related 
(P3CR) proteases which comprises also the virus-encoded proteases of comoviruses, 
potyviruses and nepoviruses. The proteases encoded by these viruses show homology in 
amino acid sequence and have similar configurations of amino acids presumably involved in 
the active site (4, 16, 20; see also Table 2). Probably the protease of the insect (picorna) 
virus cricket paralysis virus (CrPV) should also be included in this group (37). These 
different groups of viruses have moreover a very similar genome organisation and use the 
same strategy for the expression of their genetic information. The sequence homology is 
not limited to the proteases encoded by the viruses but also includes significant amino 
acid sequence homology between other proteins with presumably similar functions in viral 
RNA replication (for a more elaborate discussion about the implications of these homologies 
see 25). Gorbalenya et al. (26) noticed an homology between the active sites of the 
cellular serine proteases and the P3CR proteases, and also some homology with cellular 
cysteine proteases, and on basis thereof proposed that the P3CR proteases might form an 
evolutionary link between the serine and cysteine proteases. In our opinion i t is equally 
possible that these homologies are the result of convergent evolution since the location in 
the protein of the amino acids forming the putative active si te of the P3CR proteases 
namely a cysteine and histidine residue (4), is quite different from the location of the 
cysteine (or serine) and histidine forming the active si te in the cellular serine and 
cysteine proteases (Tables 1 and 2). The active center of the serine and cysteine proteases 
moreover contains an aspartic acid residue (see Table 1). Although there is less amino acid 
homology between the N-termini of the P3CR proteases, the sequence (Lys/Arg, Asp., aliphatic 
amino acid) is found in all P3CR proteases around amino acid position 80 (see Table 2). I t 
seems plausible that this aspartic acid residue i s also part of the active center of the 
P3CR proteases. 
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Table 2. Viral proteases. 
group viral protease type of protease as putative active site consensus consensus amino 
inferred from protease residues based on cleavage site (3) acids surrounding 
inhibitor studies (1) homology with other -1 «-1 the cleavage site 
proteases (2) 
retroviruses RSV pi5 Asp (30), Asp (95) -2, -3, -4, Pro, Ala 
Val, Leu. H e 
Asp (30). Asp (95) Tyr. Leu Pro. Ala. -4 Ser. Thr 
Thr -2 Ala. Leu 
alphaviruses nsP2 
capsid 
Ala, Gly, Ala. Gly -3 Ala. Val, Ile 
Cys Tyr -2 Gly 
His (140). Asp (145), Trp Ser -5. -3 Glu 
Ser (215) -2 Glu, Gin 
flavlviruses Arg Gly, Ser -2 Lys, Arg 
Thr. Ala 
picornavlruses 2A (4) Asp (40). Cys (110). Tyr, Thr, Gly 
His (118) Ala 
Leu, lie. Met 
coaoviruses CPHV 24 K 
Asp (80). Cys (150), Gin. Glu Gly, Ser -4 Ala, Val. 
Asp (80). Cys (150), Gin 
His (165) 
Leu, H e , Pro, Phe 
Gly, Ser, -4 Ala 
Met -2 Ala. Pro 
nepovlruses TBRV pro (5) Asp (90 ?), Cys 
(170 ?). His (185 ?) 
potyviruses TEV Nia Asp (255), Cys (340). Gin 
His (355) 
Gly, Ser -6 Glu. 
-4 Ile. Leu, Val 
-3 Tyr 
(1) A question mark indicates that the use of inhibitors did not reveal the nature of the protease. 
(2) The position of the active site residue in the protease is shown in brackets. 
(3) A question mark Indicates that the cleavage sites are not known. 
(4) Only PV, HRV and COX possess a 2A protease. 
(5) The nepovlrus protease Is not yet Identified, and Its position Is only based on amino acid homologies (see section 2.6). 
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The sequence around a conserved cysteine residue in the picornaviral 2A proteases shows 
homology with the P3CR proteases (40). A histidine is found to be conserved in the 2A 
proteases at about a similar position relative to the cysteine as the histidine of the P3CR 
proteases. The 2A proteases contain furthermore a conserved Ser/Arg, Asp, Leu sequence 
around amino acid position 40 which also may be a constituent of the active si te of these 
proteases just as was proposed for the P3CR proteases. In view of the similarities between 
the 2A protein of picornaviruses, for which this protein is a protease, and the 3C protein, 
i t is possible that the 2A gene is the result of a duplication of the 3C gene. 
A second group of virus-encoded proteases is formed by the retrovirus proteases which 
contain several conserved regions if compared among each other but show no homology with 
the other viral proteases. One of the conserved regions shows homology with the sequence 
around the aspartic acid present in the active si te of cellular acid proteases (Leu, Val, 
Asp, Thr, Gly, Ala; 71). As there are two aspartic acids involved in the active s i te of 
cellular acid proteases (Table 1) i t is of interest that in the retrovirus protease a second 
conserved sequence can be observed around an aspartic acid near position 150 suggesting 
that these two aspartic acids may constitute the active si te of the retroviral proteases. 
The sequence around amino acid position 150 (lie, Leu, Gly, Arg, Asp) bears no resemblance 
to the acid protease sequence. If these two aspartic acid residues indeed constitute the 
active site, the homology of the sequence around one of the aspartic acids of the 
retroviral proteases and that of the acid proteases might be another example of 
convergent evolution. Based on inhibition studies the retroviral protease has previously 
been characterized as a cysteine protease, but a conserved cysteine has not been found in 
these enzymes (see 62, 71). The retrovirus protease is therefore probably not a cysteine 
protease, but in view of the occurrence of the aspartic acid residues as described above, 
an acid protease. This is an example of how cautious one has to be with the interpretation 
of the results of studies with protease inhibitors (see Table 2). In caulimoviruses (plant 
DNA viruses) a protease domain related to the retrovirus protease is present (71). This 
suggests that protein processing plays a role in the expression of the caulimovirus 
genome, but at this time i t is not clear whether processing of caulimovirus proteins by 
this putative protease really takes place. 
A third group of virus-encoded proteases are the alphavirus and flavivirus proteases 
involved in the cleavages of the non-structural proteins of these viruses. The proteases 
have sofar not been characterized, but since none of the non-structural proteins of these 
viruses show homology to known viral or cellular proteases i t seems probable that these 
proteases constitute a new group within one of the four main families of proteases. 
The alphavirus capsid protease was characterized as a serine protease and was shown to 
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have a substantial amount of homology with the trypsin-like serine proteases (27). This 
homology is not limited to the amino acids forming the active site and those surrounding 
the active si te but also includes the relative position of these amino acids in the two 
proteins. It is therefore possible that the capsid protease and the trypsin-like proteases 
are derived from a common ancestor. 
For the other virus groups described in this review, proteases s t i l l have to be identified 
and sequenced. It is, however, tempting to assume, based on similarities in genome 
organisation and expression, that the TYMV and BNYW protease may be related to the 
animal alphavirus protease and that the proteases of the VPg containing plant viruses 
(PEMV, TRosV, PLRV) are related to the P3CR proteases. 
From the sequence information for cellular and viral proteases available at this moment, i t 
may be concluded that the virus-encoded proteases of most viruses have evolved rather 
independently and that homology with cellular protases is the result of convergent 
evolution. A possible exception may be the capsid protease of the alphaviruses. 
4. THE CLEAVAGE SITES 
The amino acid pairs that are cleaved by proteases encoded by different virus groups are 
shown in Table 2. Almost all viral proteases cleave their substrates between a limited set 
of amino acid pairs. The polypeptide chain usually also contains a number of the same 
amino acid pairs that are not cleaved, which implies that there are additional factors 
involved in determining the si tes that are used for proteolytic pocessing. 
When the cleavage sites shown in Table 2 are compared with each other, i t can be 
concluded that the P3CR proteases not only show amino acid sequence homology with each 
other (see section 3) but also catalyze cleavages between related amino acid pairs (Gin or 
Glu at -1 and Gly or Ser or less frequently Ala, Met, Thr, Val at +1). Each of the P3CR 
proteases is however highly specific for i t s own polyprotein and not able to cleave 
polyproteins from other viruses. The amino acid sequences surrounding the sites cleaved by 
the Picornavirus 3C proteases show no homology. At position -4 there is a preference for 
an amino acid with a hydrophobic group (Ala, Val, Leu, lie, Pro, Phe) the identity of which 
can be different for each group (see section 2.4). The sequences surrounding the si tes 
cleaved by the CPMV and potyvirus proteases show a higher degree of homology (Table 2). 
These proteases also prefer an amino acid with a hydrophobic group at position -4. The 
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Picornavirus 2A proteases, which show homology with the picornaviral 3C proteases, only 
perform a single autocatalytic cleavage at their own N-termini. These proteases cleave 
between a different subset of amino acid pairs (Tyr Gly, Ala Gly or Thr Gly) but these 
cleavage sites possess again an amino acid with a hydrophobic group at position -4. 
From this comparison i t appears probable that the hydrophobic residue at position -4 plays 
a role in determining whether a si te is used for proteolytic processing by the P3CR 
protease. 
The cleavage sites in the polyprotein between the non-structural proteins of the 
alphaviruses and flaviviruses are very well conserved. Also the amino acids at position -2 
(flaviviruses) and -2 and -3 (alphaviruses) are very well conserved (Table 2) which implies 
that si tes that are substrates for processing by these proteases are clearly defined. The 
cleavage si tes of the retrovirus proteases show some more variation. The only consensus 
found for the RSV gag protein cleavage si tes is that only aliphatic amino acids are 
present at positions -2, -3 and -4 (Table 2 and section 2.1). On the other hand, the 
cleavage si tes in the MoMuLV gag protein are rather similar (Table 2), and also show 
homology with cleavage sites in the gag protein of other retroviruses. Furthermore, 
contrary to the picornaviruses proteases, some retroviral proteases are able to cleave the 
gag precursor of related viruses. 
In summary, cleavage sites of viral proteases are usually characterized by a preference 
for certain amino acids at one or more of the positions -2, -3 , -4, -5 . It seems that amino 
acids at the (+) positions (with the exception of +1) do not have an important role in 
determining whether a site is used for proteolytic processing. This conclusion is also 
supported by experiments described by Vos et al. (79). By using si te directed mutagenesis 
on cDNA clones of M-RNA of CPMV, the cleavage si te between the two capsid proteins (Gin 
Gly) was modified. Insertion of an amino acid at the +2 position (Gin Gly Pro -» Gin Gly Arg 
Pro) did not change the efficiency of cleavage of this si te by the 24K protease in an in 
vitro assay (79). However, when the Gly in position +1 was replaced by an Ala, Met or Ser 
(amino acids which are found a t the +1 position in other cleavage sites, see above), the 
cleavages at these sites proceeded with a very low efficiency. Semler et al. (64) modified 
the cleavage si te between PV 3C and 3D by inserting a Ser in the -3 position. This s i te 
was no longer cleaved by the 3C protease indicating the importance of the amino acids at 
the (-) positions in determining a cleavage site. 
For cellular proteases, amino acids in the (-) positions are equally important in 
determining a cleavage site. Trypsin cleaves after Lys or Arg in the -1 position and V8 
protease of Staphylococcus aureus after Glu in the -1 position. Signalases only cleave at 
s i tes where certain subsets of amino acids are present a t position -1 and -3 (77, 78) and 
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substilisin has a specificity towards certain amino acids at position -4. However the great 
specificity of most viral proteases for their substrates indicates that factors like 
secondary and ter t iary structure are also important in determining which sites are cleaved 
by these proteases. 
Interestingly, almost al l new N-termini created by viral proteases consist of Gly, Ser, Ala, 
Thr, Met or Val (see Table 2). Bachmair et al. (6) recently proposed that proteins present 
in the cytoplasm which have at their N-terminus one of these amino acids have a long 
half-life (t)£ > 20 h). It is tempting to speculate that viruses have selected for proteins 
having one of these amino acids at their N-termini and therefore also for proteases having 
specificity towards these amino acids at the +1 position of cleavage sites. A notable 
exception is nsP4 of alphaviruses which has a Tyr at i t s N-terminus. These proteins have 
indeed a short half-life (tii ~ 10 m) (36 ; see section 2.2) as predicted by the N-terminal 
rule of Bachmair et ad. (6). 
5. CONCLUSIONS 
Many proteins are synthesized as precursor proteins which s t i l l require a proteolytic 
processing to produce mature active proteins. The final processing reaction is usually an 
important step in the regulation of the production of the active protein. Likewise a virus 
can regulate the processing of a polyprotein, and thus the production of active proteins 
in several ways. 1) Some cleavages only happen under certain conditions as for example 
cleavage of PV 1AB into 1A and IB which can only take place during the last steps in 
virus assembly when the RNA is present in the capsid. This is essentially a maturation 
reaction (5). 2) Cleavage products may have very different half lives as in the case of the 
alphavirus nsP4 which has a much shorter half-life than the other non-structural proteins 
(see sections 2.2 and 4). The functional significance of this difference is not yet clear. 3) 
A polyprotein can be cleaved via alternative pathways resulting in intermediates with 
different activities. The CPMV 170K protein can be cleaved in 110K and 60K products or 
87K and 84K products (see Fig. 5). Presumably the different intermediates possess different 
activit ies or have different roles in viral RNA replication. 4) In most cases the protease 
catalyzing the cleavages in a polyprotein is itself part of this protein. This offers the 
possibility to regulate the processing, as the protease can cleave intramolecularly (in cis) 
and/or intermolecularly (in trans). Usually the intramolecular cleavages are rapid for 
example the ID 2A cleavage in the PV polyprotein catalyzed by 2A. Most viral proteases 
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are able to release themselves by autocatalytic cleavages at both borders. However some 
viral proteases are also able to cleave Intramolecularly at other sites, for example the 
32K 170K cleavage in the CPMV B-RNA-encoded polyprotein catalyzed by the 24K protein as 
soon as during translation the growing polypeptide chain has reached the 24K protein 
coding region. 5) Another way to regulate occurs if cleavages take place in a specific 
order, i.e. a certain cleavage can only take place after another cleavage has been carried 
out. For example, during replication of CPMV (and Picornavirus) RNA, VPg becomes attached 
at the 5' end of newly synthesized RNA. In the case of CPMV, VPg is probably released from 
a 60K precursor which itself f irst has to be released from a 170K precursor (see Fig. 5). 
In that case the activity of the protease is closely linked up with the replication of 
viral RNA. This connection is also apparent in the remarkably conserved order of the VPg, 
protease and polymerase proteins on the genomes of picorna-, como-, poty-and nepoviruses 
(see Fig. 4, 5, 7, 8 and ref. 25). 
Recently Ypma-Wong and Sender (86) used an in vitro transcription translation system to 
show that the PI region, containing the capsid proteins 1A, B, C and D, f irs t has to be 
released from the polyprotein by action of 2A before the other cleavages in 1AECD can 
take place. Furthermore they showed that an intact 3C coding region was sufficient to 
support cleavages between 2A 2B, 2B 2C and 2C 3A, while the cleavages between the 
structural proteins IB, 1C and ID only took place in the presence of an intact 3CD coding 
region (see Fig. 4). 
The activity of a viral protease can again be regulated by other viral proteins. This has 
recently been described for the 24K protease of CPMV which has to be associated with the 
32K protein for cleaving the Gin Met si te in the M-polyprotein (see Fig. 5; 79). 
In conclusion i t is apparent that RNA viruses that express their viral genomic RNA or part 
of i t by polyprotein synthesis and proteolytic processing encode their own proteases. The 
proteolytic processing proceeds in successive steps and appears to have a regulatory role 
in the expression of viral encoded functions. There are a number of different viral 
encoded proteases, which appear to have evolved independently from each other and from 
existing cellular proteases. The viral encoded proteases are highly specific in recognizing 
only the polyprotein of i t s own virus. Usually the proteases are part of the polyprotein 
that is proteolytically cleaved by them and presumably the proteases have evolved as a 
part of the polyprotein. It provides the virus with a method of regulating the production 
of proteins involved in viral RNA replication and virus assembly. 
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The bottom-component RNA (B-RNA) of cowpea mosaic virus is expressed by the production of a 
—200,000-daIton polyprotein (200K polyprotein), from which the functional proteins are formed by specific 
proteolytic cleavages. Partial amino-terminal sequences of the various B-RN A-encoded proteins have now been 
determined. Comparison of the information obtained with the B-RNA sequence allowed the localization of the 
coding regions for these proteins on B-RNA, the calculation of their precise molecular weights, and the 
determination of the cleavage sites at which they are released from the polyprotein precursor. Sequence 
analysis of the 32K protein, which is derived from the amino-terminal end of the 200K polyprotein, indicated 
that the AUG codon at nucleotide position 207 of the RNA sequence is the translation initiation codon. Sequence 
analysis of the 170K, 110K, 87K, 84K, 60K, and 58K proteins revealed the existence of three types of cleavage 
site in the 200K polyprotein: glutamine-serine (two sites), glutamine-methionine (one site), and glutamine-
glycine (one site) amino acid pairs. The nature of these cleavage sites suggested that two different viral proteases 
are involved in the processing of the B-RNA-encoded polyprotein. 
The genetic information of cowpea mosaic virus (CPMV) 
is organized in two separately encapsidated plus-strand 
RNA molecules which are characterized by a small protein, 
denoted VPg, covalently bound to their 5' ends and a 
poly(A) tail at their 3' ends (for a review, see references 4 
and 14a). The expression of both RNAs involves the pro-
duction of large polyproteins that are subsequently proc-
essed by proteolytic cleavage into smaller, functional pro-
teins (7, 8, 11, 25). The nucleotide sequences of the smaller 
middle-component RNA (M-RNA) (3,481 nucleotides) and 
the larger bottom-component RNA (B-RNA) (5,889 nucleo-
tides) reveal a single, long open reading frame in each of 
them, confirming polyprotein processing as their mode of 
expression (20, 30). M-RNA has been shown to possess two 
translation initiation sites and is translated in vitro into two 
overlapping primary translation products of —105,000 and 
—95,000 daltons which differ only in their amino-terminal 
sequences (Fig. 1; 7, 14, 22). Proteolytic cleavage of these 
proteins occurs at two different sites. The first cleavage is at 
a glutamine-methionine dipeptide sequence, resulting in 
products of 60,000, 58,000, and 48,000 daltons (7, 30; H. 
Franssen, Ph.D. thesis, Agricultural University, Wageningen, 
The Netherlands, 1984). Subsequent cleavage of the 60,000-
dalton intermediate (60K intermediate) at a glutamine-
glycine sequence releases the two capsid proteins VP37 
(37,000 daltons) and VP23 (23,000 daltons) (30; Franssen, 
Ph.D. thesis). B-RNA produces a single 200K polyprotein 
from which, in addition to 170K, U0K, 84K, and 60K 
intermediates, five final cleavage products are derived in the 
order NH2-32K-58K-4K (VPg)-24K-87K-COOH (Fig. 1; 
11). 
Information about the nature of the various cleavage sites 
in the B-RNA-encoded polyprotein (B-polyprotein) is still 
rather poor. Mapping of the amino-terminal end of VPg on 
the open reading frame of B-RNA demonstrated that this 
protein is released from its precursor at this terminus by 
cleavage at a glutamine-serine site (31). Inspection of the 
* Corresponding author. 
theoretical sequence of the 200K polyprotein has led to the 
suggestion that all cleavages may occur at glutamine-serine 
sites (31). 
To understand in more detail the proteolytic processing 
pathway of the B-polyprotein, we have now determined 
partial amino-terminal sequences of its cleavage products by 
automated Edman degradation with radiolabeled protein 
samples (26). Comparison of the amino acid sequence data 
obtained with the nucleotide sequence of B-RNA allowed 
the determination of the cleavage sites in the B-polyprotein 
and predicted the molecular sizes of all cleavage products. 
The data presented in this paper demonstrate the existence 
of three different types of cleavage site and suggest that two 
different proteases are involved in the processing of the 
B-polyprotein. 
MATERIALS AND METHODS 
Virus and plants. CPMV (Sb isolate) was propagated in 
cowpea plants (Vigna unguiculata L., California blackeye) 
as described previously (18, 29). Purified B-components 
were obtained by repeated sucrose gradient centrifugation as 
described in detail before (12). 
Infection of cowpea protoplasts and labeling of proteins. 
Mesophyll protoplasts were prepared from 10-day-old pri-
mary cowpea leaves and inoculated with purified CPMV 
B-components as previously described (15, 25). To label 
viral proteins, we incubated protoplast suspensions (5 ml, 5 
x 105 cells per ml) in the presence of [35S]methionine (1,000 
Ci/mmol; New England Nuclear Corp., Boston, Mass.) or 
[3H]leucine (150 Ci/mmol; Amersham Corp., Arlington 
Heights, 111.). Radioactive amino acid was supplied in two 
portions ([ ,5S]mefhionine, 150 u,Ci; [3H)leucine, 750 u.Ci) at 
18 h and 25 h after inoculation. At 42 h after inoculation, 
cells were harvested by centrifugation (2 min, 600 x g) and 
disrupted by suspension in 0.5 ml of TKEDP buffer (50 mM 
Tris-acetate [pH 7.4], 10 mM potassium acetate, 1 mM 
EDTA, 10 mM dithiothreitol, 1 mM phenylmethylsulfonyl 
fluoride). The lysate obtained was centrifuged for 30 min at 
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FIG. 1. Model of the proteolytic processing of the primary translation products of CPMV M-RNA and B-RNA. Open reading frames in 
both RNAs are indicated by double-lined bars, VPg is indicated by a black box, and all other proteins are indicated by single lines. For further 
details, see the text. 
30,000 x g and 4°C, yielding the 30,000 x g supernatant, 
which served as the source of radiolabeled viral proteins. 
Immunoprecipitation of viral proteins. As a first step in the 
purification of the 32K, 58K, 60K, 84K, and 170K proteins, 
these proteins were coprecipitated from the 30,000 x g 
supernatant of B-component-inoculated protoplasts with an-
ti-32K serum under nondenaturing conditions (10). For this 
purpose, 140 p.1 of anti-32K serum was mixed with 500 |xl of 
the 30,000 x g supernatant, and the mixture was diluted with 
TKE buffer (50 mM Tris-acetate [pH 7.4], 10 mM potassium 
acetate, 1 mM EDTA) to a final volume of 2,000 (j-1. After 
incubation for 4 h at 4°C, 560 p.1 of a 10% (wt/vol) suspension 
of Staphylococcus aureus cells (IgGsorb; Enzyme Center 
Inc., Boston, Mass.) in TKE buffer was added, and incuba-
tion was continued for 1 h at 4°C. S. aureus cells with bound 
immunocomplexes were precipitated by centrifugation 
through a sucrose cushion as previously described (7). The 
32K, 58K, 60K, 84K, and 170K viral proteins present in the 
precipitate were separated by electrophoresis in a 7.5 or 10% 
sodium dodecyl sulfate-polyacrylamide gel as previously 
described (25). The supernatant left after removal of the 
immunoprecipitate was used for the isolation of the 87K 
protein, free of the 84K protein. 
Isolation of viral proteins from Polyacrylamide gels. Viral 
proteins separated in preparative Polyacrylamide gels and 
localized by autoradiography were eluted from nonstained 
gel strips by using an ISCO 1759 sample concentrator (3) at 
180 V for 6 h at 4°C. The sample compartment buffer 
contained 25 mM Tris, 192 mM glycine, 0.1% sodium 
dodecyl sulfate, and 50 u,g of horse heart cytochrome c 
(Calbiochem-Behring, La Jolla, Calif.) per ml as the carrier 
protein. Eluates were concentrated by using a Centricon-30 
microconcentrator (Amicon Corp., Danvers, Mass.) and 
brought to 10 mM Tris hydrochloride (pH 7.2H).02% so-
dium dodecyl sulfate. 
Protein sequence analysis. Sequencing of radiolabeled pro-
teins was performed by the method of Beyreuther et al. (2) 
with some modifications (31). Control experiments were 
performed to minimize the nonspecific release of radioactiv-
ity, especially at cycle 1 of Edman degradation. This was 
achieved with a single complete nondegradative washing 
cycle by omitting the delivery of the coupling agent 
phenylisothiocyanate. A spinning-cup sequencer (Beekman 
Instruments model 890) and a gas-liquid solid-phase se-
quencer (Applied Systems model 470A) were both used. The 
performance of the sequencer was monitored with 1% of the 
sample for each degradation cycle by high-performance 
liquid chromatography of the phenylthiohydantoin deriva-
tives released from a second carrier protein. To do this, we 
used performic acid-oxidized tysozyme (1.45 mg for the 
spinning-cup sequencer and 0.145 mg for the gas-liquid 
solid-phase sequencer), since the carrier cytochrome c 
added prior to gel elution of the viral proteins is N terminally 
blocked. Polybrene (1.5 mg for both sequencers) was added 
as the nonprotein carrier. Identification of phenylthiohydan-
toin derivatives by high-performance liquid chromatography 
was done as described previously (1). The radioactivity from 
90% of the sample released during each degradation cycle 
was dissolved in 0.1 ml of methanol and determined in 10 ml 
of Aquasol 2 (New England Nuclear Corp.) by using a 
Packard Tri-Carb liquid scintillation counter. 
RESULTS 
Preparation of radiolabeled viral proteins. In previous 
experiments we showed that upon inoculation of cowpea 
protoplasts with B-components, B-RNA is efficiently repli-
cated in the absence of M-RNA, resulting in the overpro-
duction of B-RNA-encoded proteins (12, 25). This finding 
was now used to obtain these viral proteins in quantities 
sufficient for radiochemical sequencing. Cowpea protoplasts 
were inoculated with purified B-components and labeled 
with [3H]leucine or [35S]methionine. A typical 30,000 x g 
supernatant fraction obtained from such protoplasts incu-
bated with [35S]methionine is shown in Fig. 2, lane B. While 
the 170K, 110K, 87K, 60K, 58K, and 32K. proteins were 
directly detectable in such extracts, the 84K protein was 
mostly marked by host protein bands or present in amounts 
too low to allow its detection. This protein could, however, 
readily be detected in immunoprecipitates of 30,000 x g 
supernatant fractions obtained with antiserum raised against 
the 32K protein (Fig. 2, lane J). As a first step in the 
purification of the 170K, 84K, 60K, 58K, and 32K proteins, 
larger quantities of 30,000 x g supernatant fractions from 
[3H]leucine- or [35S]methionine-labeled cells were subjected 
to immunoprecipitation with anti-32K serum, and the pre-
cipitates obtained were electrophoresed in preparative Poly-
acrylamide gels (data not shown). The viral proteins were 
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subsequently isolated from gel slices by electrocution. The 
87K protein was simultaneously obtained from the superna-
tant fraction of such immunoprecipitation reactions. The 
110K protein, finally, was directly excised and eluted from 
preparative gels of an unfractioned 30,000 x g supernatant 
fraction. To verify whether the viral proteins thus obtained 
were pure and intact, we analyzed aliquots by gel electro-
phoresis (Fig. 2, lanes C to I). 
Amino acid sequence analysis of the 32K protein. Since 
translation studies have already shown that the 32K protein 
is derived from the amino-terminal part of the 200K poly-
protein (11), sequencing of this protein would allow the 
precise determination of the translation initiation site of 
B-RNA. Radiochemical sequencing revealed that this pro-
tein contains leucine residues at positions 2, 12, 13, 16, 29, 
30, and 33 (Fig. 3A) and a methionine residue at position 24 
(Fig. 3B). Comparison of these results with the nucleotide 
sequence of B-RNA (20) determined a unique amino-
terminal coding location for this protein starting at nucleo-
tide position 210, i.e., one codon downstream of the AUG 
codon which heads the long open reading frame in B-RNA. 
Thus, the amino-terminal sequence of the 32K protein 
demonstrated that this AUG codon at nucleotide position 
207 represents the (unique) translation initiation site of 
B-RNA and that the first methionine residue of the transla-
tion product is posttranslationally removed. There seems to 
be one discrepancy between the partial amino acid sequence 
of the 32K protein and the nucleotide sequence of B-RNA. 
From the triplet sequence in the open reading frame in 
B-RNA (20) a valine residue is expected at amino acid 
position 33 instead of the leucine residue found (Fig. 3A). 
However, a single point mutation at nucleotide position 306 
could have occurred, converting the valine triplet into a 
leucine triplet (GUC -» CUC). 
Amino acid sequence analysis of the 170k, 84K, 60K, and 
S8K proteins. Primary cleavage of the 200K polyprotein 
yielded a 32K protein and a 170K protein. For localization of 
the coding region for the 170K protein on B-RNA, purified 
samples of this protein, labeled with either [3H]leucine or 
[35S]methionine, were subjected to sequence analysis. The 
results showed that leucine is present at positions 6, 7, 10, 
and 22 (Fig. 4A) and that methionine is present at position 14 
(Fig. 4B). This amino acid arrangement is consistent with a 
coding region for the 170K protein beginning at nucleotide 
position 1185 in the B-RNA sequence and reveals that the 
amino-terminal residue of this protein is serine (Fig. 4). 
Further inspection of the B-RNA sequence (20) revealed that 
this amino-terminal residue is preceded by a glutamine in the 
precursor protein. These data strongly suggest that the 170K 
protein is generated by proteolytic cleavage at a glutamine-
serine dipeptide sequence. According to the scheme in Fig. 
1, further proteolytic cleavage of the 170K protein would 
yield 84K, 60K, and 58K proteins, all sharing their amino-
terminal sequences with the 170K protein. To verify this 
hypothesis, we carried out additional sequence analyses on 
these cleavage products, labeled at either their leucine or 
methionine residues. Leucine and methionine residues were 
indeed detected in all three proteins at the same locations as 
in the 170K protein (Fig. 4C to H). These results confirm the 
positions of these proteins in the processing map of Fig. 1 
and, moreover, demonstrate that their amino termini are 
completely identical to that of the 170K protein and not 
subject to terminal trimming. 
Amino acid sequence analysis of the 110K and 87K proteins. 
The 110K and 87K proteins are expected to be derived from 
the carboxy-terminal half of the 200K polyprotein, both 
anti-
input purified proteins 32K 
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FIG. 2. Electrophoretic analysis of purified viral proteins used 
for sequence determinations. Viral proteins labeled in vivo with 
[15S]methionine were purified from a 30,000 x g supernatant fraction 
of B-component-inoculated cowpea protoplasts (lane B). As a first 
step in the purification of the 170K, 84K, 60K, 58K. and 32K 
proteins, this supernatant fraction was subjected to immunoprecip-
itation with antibodies raised against the 32K protein (lane J). For 
further details, see the text. The proteins obtained were 
reelectrophoresed to test their quality (lanes C to I). Lane A 
contains the 30,000 x # supernatant fraction from [35S)methionine-
labeled noninoculated protoplasts. M.W., Molecular weight. 
having different amino termini. For the 110K protein, sam-
ples labeled with [3H]leucine or [35S]methionine were sub-
jected to sequence analysis. The results showed that in this 
protein, leucine is present at positions 3 and 18 (Fig. 5A) and 
methionine is present at positions 1,11, and 30 (Fig. 5B and 
C). These data are consistent with a unique coding region for 
the 110K protein beginning at nucleotide position 3048 in the 
B-RNA sequence (20) and identify the amino-terminal resi-
due of this protein as a methionine (Fig. 5). It should be 
noted that different preparations of this protein showed some 
heterogeneity, which could easily be explained by variable 
demethionylation in vivo. For instance, the sequence anal-
ysis shown in Fig. 5A reveals that some [3HJleucine label 
was released in cycles 2 and 17. Equally, in the analysis 
shown in Fig. 5B, some [35S]methionine label was released in 
cycle 10, whereas in a second [35S]methionine-labeled pro-
tein sample (Fig. 5C), most of this label was found in cycle 
10, with decreased label release in cycles 1 and 11. Inspec-
tion of the B-RNA sequence (20) demonstrated that the 
amino-terminal methionine of the 110K protein is preceded 
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FIG. 3. Radiochemical amino-terminal sequence analysis of the 32K protein encoded by CPMV B-RNA. Purified 32K protein labeled with 
[3H]leucine (A) or [35S]methionine (B) was subjected to automated Edman degradation as described in detail in Materials and Methods. The 
radioactivity released during each Edman degradation cycle is plotted versus the cycle number. The predicted amino-terminal sequence of 
the 32K protein is given at the bottom of each panel, with the amino acids whose positions are considered proven by the presented data being 
underlined. (M) refers to the methionine residue encoded by the initiation codon, which is posttranslationally removed. The amounts of 
radioactivity applied to the sequencer were as follows: A, 39,000 cpm of I'fflleucine; B, 30,000 cpm of ["SJmethionine. 
by a glutamine in the 200K polyprotein, indicating that the 
110K protein is released from its direct 170K precursor by 
proteolytic cleavage at a glutamine-methionine dipeptide 
sequence. Sequence analysis of purified, radiolabeled 87K 
protein samples revealed the presence of a leucine at posi-
tion 9 and a methionine at position 21 (Fig. 6). Combined 
with the proteolytic processing map of the 200K polyprotein 
(Fig. 1), these analyses allowed the localization of the coding 
region for the 87K protein beginning at nucleotide position 
3672 in the B-RNA sequence. The mapping of the 87K 
protein on the open reading frame of B-RNA indicated 
further that the amino-terminal residue of this protein is a 
glycine and that it must be derived from longer precursors by 
cleavage at a glutamine-glycine dipeptide sequence. 
DISCUSSION 
Initiation site of B-RNA translation. A summary of the 
protein sequence analyses presented in this paper is sche-
matically illustrated in Fig. 7. The exact location of the 
amino-terminus of each of the proteins in the B-polyprotein 
is indicated by different symbols, depending on the nature of 
the cleavage sites used for their release. Analysis of the 32K 
protein allowed the identification of the AUG codon at 
position 207, the first AUG codon in the open reading frame 
of B-RNA (20), as the initiation codon for the synthesis of 
the 200K polyprotein. This initiation codon is also the AUG 
codon nearest to the 5' end of the RNA, while the surround-
ing nucleotide sequence CCAACAUGG conforms almost 
perfectly to the consensus sequence around eucaryotic ini-
tiation codons (CCA/GCCAUGG), as described by Kozak 
(19). The 32K protein lacks the amino-terminal methionine 
derived from this AUG codon, apparently because of post-
translational demethionylation, a widely occurring cellular 
process. As a consequence, the first residue of the 32K 
protein is glycine (Fig. 3). 
Proteolytic cleavage sites in the B-polyprotein. Addition-
ally, the protein sequence analyses revealed the presence of 
three different types of processing signal in the 200K precur-
sor: a glutamine-serine pair (two sites), a glutamine-
methionine pair (one site), and a glutamine-glycine pair (one 
site) (Fig. 7). While the last two types of cleavage site have 
also been found in the M-RNA polyproteins (30; Franssen, 
Ph.D. thesis), the glutamine-serine cleavage sites appear to 
be unique to the B-polyprotein. 
Cleavage at the glutamine-glycine dipeptide sequence 
(Fig. 7) is consistent with computer comparisons which 
showed that the two regions within the 200K polyprotein of 
CPMV which are homologous to the polioviral protease and 
polymerase are separated at this glutamine-glycine pair (9). 
However, the glutamine-methionine cleavage site from 
which the 110K protein is released was totally unexpected. 
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FIG. 5. Partial sequence analysis of the 110K protein encoded by 
CPMV B-RNA. Purified 110K protein labeled with I'HJleucine (A) 
or ["Sjmethionine (B and C) was subjected to automated Edman 
degradation. For further explanation of the graphs, see the legend to 
Fig. 3. The amounts of radioactivity applied to the sequencer were 
as follows: A, 74,000 cpm of [3H]leucine; B, 31,000 cpm of 
[35S]methionine; C, 41,000 cpm of [35S]methionine. 
As a consequence, VPg, the sequence of which preceeds 
that of the 110K protein within the 200K polyprotein (11,13), 
is not released by cleavages at identical sites (glutamine-
serine pairs), as proposed by us in a previous paper (31), but 
at two different sites: a glutamine-serine pair (at amino acid 
positions 919 and 920; Fig. 7) is used to generate its amino 
terminus, and a glutamine-methionine pair (at positions 947 
and 948; Fig. 7) is now predicted to generate its carboxy 
terminus. VPg would thus have a length of 28 residues, 
instead of 33 residues, as previously proposed (31), which 
indeed is more consistent with the length of VPg found for 
the related picornaviruses (21 to 24 residues) (5, 6,16,17, 21, 
24, 27, 28). 
Comparison of the amino acid sequences surrounding all 
cleavage sites in the polyproteins encoded by both CPMV 
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Q. 
o 
T—i—I—I—'—i—i—i—i—I—i—i—i—i—I—i—r 
10 15 20 
G A E E Y F D F L P A E E N V S S G V A M V A 
B 
[36S] Met 
Residue 
FIG. 6. Partial amino-terminal sequence analysis of the 87K 
protein encoded by CPMV B-RNA. Purified 87K protein labeled 
with [3H]leucine (A) or [3!S]methionine (B) was subjected to auto-
mated Edman degradation. For further explanation of the graphs, 
see the legend to Fig. 3. The amounts of radioactivity applied to the 
sequencer were as follows: A, 140,000 cpm of ('H)leucine; B, 40,000 
cpm of [35S]methionine. 
RNAs revealed that these sequences are rather variable, 
with similar amino acid residues at only two positions (Table 
1). In five of six cleavage sites, alanine is found at position 
- 4 , while either alanine or proline is found at position - 2 . It 
is noteworthy that alanine at position - 4 is also found in 
most (five of nine) glutamine-glycine cleavage sites in the 
polyprotein of poliovirus (17). Furthermore, inspection of 
the predicted amino acid sequence of the polyproteins 
encoded by B-RNA and M-RNA revealed the presence of 11 
glutamine-glycine pairs, 7 glutamine-serine pairs, and 4 
glutamine-methionine pairs which are not used for 
proteolytic processing. For only 3 of these 22 sites, alanine is 
found at position —4 (data not shown), further supporting the 
idea that the occurrence of such a residue at position - 4 may 
represent an important signal. Besides, it is very likely that, 
more than simply the surrounding sequences, factors like 
secondary structure, such as ß-turns, and hydrophilicity are 
involved in determining the sites used for proteolytic proc-
essing. 
Molecular weights of the B-RNA-encoded proteins. Assum-
ing that the cleavage products of the 200K polyprotein do not 
undergo any trimming at their carboxy termini, as is the case 
for picornaviral proteins, the mapping of the amino-terminal 
FIG. 4. Partial amino acid sequence analysis of the CPMV B-RNA-encoded 170K, 84K, 60K, and 58K proteins. Purified proteins labeled 
in vivo with [3H]leucine (A, C, E, and G) or [3sS]methionine (B, D, F, and H) were subjected to automated Edman degradation. The 
radioactivity released during each Edman degradation cycle is plotted versus the cycle number. The predicted amino-terminal sequence of 
the 170K, 84K, 60K, and 58K proteins is given at the top of panels A and B, with the amino acids whose positions are considered proven by 
the presented data being underlined. The amounts of radioactivity applied to the sequencer were as follows: A, 148,000 cpm of [3H]leucine; 
B, 145,000 cpm of [35S]methionine; C, 85,000 cpm of [3H]leucine; D, 37,500 cpm of ("Slmethionine; E, 103,000 cpm of ['HJleucine; F, 17,000 
cpm of [35S]methionine; G, 122,000 cpm of [3H]leucine; H, 25,000 cpm of ("Slmethionine. 
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FIG. 7. Scheme of the proteolytic processing of the 200K polyprotein encoded by CPMV B-RNA. Nucleotide positions in the open reading 
frame in the RNA refer to the first nucleotide of the codon specifying the amino-terminal residue of the various proteins released from the 
200K. polyprotein. The proteins are indicated by single lines and are not drawn to scale. The numbers in parentheses represent the molecular 
weights (103) of the proteins determined from the data presented in this paper (see also Table 2). The UAG codon at position 5805 of the RNA 
is proposed to represent the translation termination codon. Cleavage sites are indicated as follows: • , Gln-Ser: A. Gln-Gly; • . Gin-Met. 
ends of these products on the B-RNA sequence allows the 
calculation of their molecular weights (Table 2). For some 
proteins, the difference between their apparent molecular 
weights in Polyacrylamide gels (on which the nomenclature 
of the CPMV proteins has been based) and their calculated 
molecular weights was relatively small, whereas for other 
proteins, this difference was more .significant. The most 
striking discrepancy was found for the 87K and 84K pro-
teins, which had calculated molecular weights of approxi-
mately 80,000 and 93,000, respectively (Table 2), suggesting 
that the 87K protein would run faster in sodium dodecyl 
sulfate-polyacrylamide gels than the 84K protein, which is 
not the case. Although additional cleavage or trimming at the 
carboxy-terminal end of the 84K protein cannot be ruled out, 
it is more likely that one (or both) of these proteins has a 
very deviant electrophoretic behavior in Polyacrylamide 
gels. In this context, it is worthwhile mentioning that the 
proteins derived from the carboxy-terminal part of the 170K 
protein (110K and 87K) had calculated molecular weights 
approximately 7,000 lower than their apparent molecular 
weights; on the other hand, the proteins derived from the 
amino-terminal part of the 170K protein (84K, 60K, and 
58K) all had calculated molecular weights approximately 
9,000 higher than their apparent molecular weights. The 
similar deviations in apparent molecular weights found for 
these two sets of overlapping proteins indeed provide evi-
dence that the reversed order in apparent sizes of the 87K 
and 84K proteins is due to specific conformations of these 
products. 
Proteolytic activities involved in the cleavages. Another 
intriguing question to be resolved is which protease(s) is 
involved in the various cleavage steps during processing of 
the 200K polyprotein. It has now become clear that this 
polyprotein contains three different types of cleavage site. 
Although all cleavage sites share a glutamine residue in the 
first position, the residues in the second position have 
different properties. Serine and glycine both have small polar 
side chains, whereas methionine has a rather large, nonpolar 
side chain. It is therefore very unlikely that a single 
proteolytic enzyme is responsible for all these cleavages. 
Indeed, in vitro translation and proteolytic processing stud-
ies (8, 23) and in vivo inhibition studies with zinc ions (J. 
Wellink, unpublished results) suggest that the activity in-
volved in the generation of the 87K and 84K protein pair 
(recognizing the glutamine-glycine cleavage site) and the 
activity involved in the generation of the 110K and 60K 
protein pair (recognizing the glutamine-methionine cleavage 
site) have different identities. In a previous report (10), we 
presented evidence that the 32K protein possesses the 
proteolytic activity involved in cleavage at the glutamine-
meth ion ine c leavage site in the M - R N A - e n c o d e d 
polyproteins. It is therefore very tempting to assume that 
this protein is also responsible for cleavage at an identical 
site in the B-RNA-encoded polyprotein. This remains to be 
TABLE 1. Amino acids surrounding the proteolytic cleavage sites in the polyproteins encoded by CPMV B-RNA and M-RNA 
Cleavage sites" 
in polyproteins 
encoded by: 
B-RNA 
32K-58K 
58K-VPg 
VPg-24K 
24K-87K 
M-RNA 
58K-VP37 
VP37-VP23 
- 4 
Asp 
Ala 
Ala 
Ala 
Ala 
Ala 
- 3 
Asn 
Glu 
Asp 
Gin 
Phe 
He 
- 2 
Ala 
Pro 
Ala 
Ala 
Pro 
Ala 
Amino acid at 
- 1 
Gin 
Gin 
Gin 
Gin 
Gin 
Gin 
position: 
1 
Ser 
Ser 
Met 
Gly 
Met 
Gly 
2 
Ser 
Arg 
Ser 
Ala 
GIu 
Pro 
3 
Pro 
Lys 
Leu 
GIu 
Gin 
Val 
4 
Val 
Pro 
Asp 
GIu 
Asn 
Cys 
' See Fig. 1. 
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TABLE 2. Molecular weights of the CPMV proteins 
Proteins 
B-RNA encoded 
M-RNA encoded 
Apparent (from 
electrophoresis) 
200,000 
170,000 
110,000 
87,000 
84,000 
60,000 
58,000 
32,000 
24,000 
4,000 (VPg) 
105,000 
95,000 
58,000 
48,000 
37,000 (VP37) 
23,000 (VP23) 
Mol wt 
Calculated (from mapping 
on RNAs) 
209,667 
173,065 
103,140" 
79,970 
93,113 
69,812 
66,292 
36,449" 
23,319 
3,538 
116,219 
102,329 
51,847 
37,957 
40,700 
23,708 
" Corrected for removal of the first methionine residue. 
verified. Furthermore, since the 24 K. protein derived from 
the amino-terminal part of the 110K protein (Fig. 1) exhibits 
sequence homology to protease 3C of picornaviruses (9), it is 
the logical candidate for a second protease. Although its 
activity still must be determined, we propose that this 24K 
protein is involved in cleavages at both glutamine-serine and 
glutamine-glycine dipeptide sequences. 
ACKNOWLEDGMENTS 
We thank K. Neifer and S. Pinto for excellent technical assistance 
in the sequence analysis, Piet Madern for photography and artwork, 
and Gré Heitkönig for typing the manuscript. 
This work was supported by The Netherlands Foundation for 
Chemical Research (S.O.N.) with financial aid from The Nether-
lands Organisation for the Advancement of Pure Research (Z.W.O.) 
to R.G. and by grants from the Deutsche Forschungsgemeinschaft 
through SFB74, the Bundesministerium für Forschung und 
Technologie, and the Fonds der Chemischen Industrie to K.B. 
LITERATURE CITED 
1. Beyreuther, K., B. Bieseler, J. Bovens, R. Dildrop, K. Neifer, K. 
Stuber, S. Zaiss, R. Ehring, and P. Zabel. 1983. Microsequence 
analysis of peptides and proteins, p. 303-325. In H. Tscheche 
(ed.), Modern methods in protein chemistry. Walter de Gruyter 
& Co., Berlin. 
2. Beyreuther, K., R. Ehring, P. Overath, and J. K. Wight. 1980. 
Microsequence analysis of lactose permease of Escherichia coli, 
p. 199-212. In C. Birr (ed.). Methods in peptide and protein 
^sequence analysis. Elsevier Biomedical Press, Amsterdam. 
3_^  Bhown, A. S., J. E. Mole, F. Hunter, and C. J. Bennett. 1980. 
'High sensitivity sequence determination of proteins quantita-
tively recovered from sodium-dodecyl sulfate gels using an 
improved electrodialysis procedure. Anal. Biochem. 103: 
184-190. 
4. Bruening, G. 1981. Biochemistry of plant viruses, p. 571-631. In 
A. Marcus (ed.), The biochemistry of plants, vol. 6. Proteins 
and nucleic acids. Academic Press, Inc., New York. 
5. Forss, S., and H. Schaller. 1982. A tandem repeat gene in a 
Picornavirus. Nucleic Acids Res. 10:6441-6450. 
6. Forss, S., K. Strebel, E. Beck, and H. Schaller. 1984. Nucleotide 
sequence and genome organisation of foot-and-mouth disease 
virus. Nucleic Acids Res. 12:6587-6601. 
7. Franssen, H., R. Goldbach, M. Broekhuij'sen, M. Moerman, and 
A. van Kammen. 1982. Expression of middle-component RNA 
12 
13 
of cowpea mosaic virus: in vitro generation of a precursor to 
both capsid proteins by a bottom-component RNA-encoded 
protease from infected cells. J. Virol. 41:8-17. 
8. Franssen, H., R. Goldbach, and A. van Kammen. 1984. Trans-
lation of bottom component RNA of cowpea mosaic virus in 
reticulocyte lysate: faithful proteolytic processing of the pri-
mary translation product. Virus Res. 1:39-49. 
9. Franssen, H., J. Leunissen, R. Goldbach, G. Lomonossoff, and 
D. Zimmern. 1984. Homologous sequences in non-structural 
proteins from cowpea mosaic virus and picornaviruses. EMBO 
J. 3:855-861. 
10. Franssen, H., M. Moerman, G. Rezelman, and R. Goldbach. 
1984. Evidence that the 32,000-dalton protein encoded by bot-
tom-component RNA of cowpea mosaic virus is a proteolytic 
processing enzyme. J. Virol. 50:183-190. 
11. Goldbach, R., and G. Rezelman. 1983. Orientation of the cleav-
age map of the 200-kilodalton polypeptide encoded by the 
bottom-component RNA of cowpea mosaic virus. J, Virol. 
46:614-619. 
Goldbach, R., G. Rezelman, and A. van Kammen. 1980. Inde-
pendent replication and expression of B-component RNA of 
cowpea mosaic virus. Nature (London) 286:297-300. 
Goldbach, R., G. Rezelman, P. Zabel, and A. van Kammen. 
1982. Expression of the bottom-component RNA of cowpea 
mosaic virus: evidence that the 60-kilodalton VPg precursor is 
cleaved into single VPg and a 58-kilodalton polypeptide. J. 
Virol. 42:630-635. 
14. Goldbach, R. W., J. G. Schilthuis, and G. Rezelman. 1981. 
Comparison of in vivo and in vitro translation of cowpea mosaic 
virus RNAs. Biochem. Biophys. Res. Commun. 99:89-94. 
14a.Goldbach, R., and A. van Kammen. 1986. Structure, replication 
and expression of the bipartite genome of cowpea mosaic virus, 
p. 83-120. In J. W. Davies (ed.), Molecular plant virology, vol. 
2. CRC Press, Boca Raton, Fla. 
15. Hibi, T., G. Rezelman, and A. van Kammen. 1975. Infection of 
cowpea mesophyll protoplasts with cowpea mosaic virus. Vi-
rology 64:308-318. 
16. Kitamura, N., C. J. Adler, P. G. Rothberg, J. Martinko, S. G. 
Nathenson, and E. Wimmer. 1980. The genome-linked protein of 
picornaviruses. VII. Genetic mapping of poliovirus VPg by 
protein and RNA sequence studies. Cell 21:295-302. 
17. Kitamura, N., B. Semler, P. G. Rothberg, G. R. Larson, C. J. 
Adler, A. J. Dorner, E. A. Eniini. R. Hanecak, J. J. Lee, S. van 
der Werf, C. W. Anderson, and E. Wimmer. 1981. Primary 
structure, gene organisation and polypeptide expression of 
poliovirus RNA. Nature (London) 291:547-553. 
Klootwyk, J., I. Klein, P. Zabel, and A. van Kammen. 1977. 
Cowpea mosaic virus RNAs have neither m7GpppN . . . nor 
mono-, di-, or triphosphates at their 5'-ends. Cell 11:73-82. 
Kozak, M. 1984. Compilation and analysis of sequences up-
stream from the translational start site in eukaryotic mRNAs. 
Nucleic Acids Res. 12:857-872. 
Lomonossoff, G. P., and M. Shanks. 1983. The nucleotide 
sequence of cowpea mosaic virus B-RNA. EMBO J. 2:2253-
2258. 
Palmenberg, A. C., E. M. Kirby, M. R. Janda, N. L. Drake, 
G. M. Duke, K. F. Potratz, and M. S. Collett. 1984. The 
nucleotide and deduced amino acid sequences of the encephalo-
myocarditis viral polyprotein coding region. Nucleic Acids Res. 
12:2969-2983. 
Pelham, H. R. B. 1979. Synthesis and proteolytic processing of 
cowpea mosaic virus proteins in reticulocyte lysates. Virology 
96:463^(77. 
Peng, X. X., and D. S. Shih. 1984. Proteolytic processing of the 
proteins translated from the bottom-component RNA of cowpea 
mosaic virus. J. Biol. Chem. 259:3197-3201. 
24. Racaniello, V. R., and D. Baltimore. 1981. Molecular cloning of 
poliovirus cDNA and determination of the complete nucleotide 
sequence of the viral genome. Proc. Natl. Acad. Sei. USA 
78:4887-4891. 
Rezelman, G., R. Goldbach, and A. van Kammen. 1980. Expres-
sion of bottom-component RNA of cowpea mosaic virus in 
cowpea protoplasts. J. Virol. 36:366-373. 
18 
19. 
20 
21 
22 
23. 
25 
43 
WELLINK ET AL. J. VIROL. 
26. Semler, B. L., C. W. Anderson, N. Kitamura, P. G. Rothberg, common cold virus: human rhinovirus 14. Nucleic Acids Res. 
W. L. Wishart, and E. Wimmer. 1981. Poliovirus replication 12:7859-7877. 
proteins: RNA sequence encoding P3-lb and the sites of 29. Van Kammen, A. 1967. Purification and properties of the 
proteolytic processing. Proc. Natl. Acad. Sei. USA 78: components of cowpea mosaic virus. Virology 31:633-642. 
3464-3468. 30. Van Wezenbeek, P., J. Verver, J. Harmsen, P. Vos, and A. van 
27. Skern, T., W. Sommergruber, D. Blaas, P. Gruendler, F. Kammen. 1983. Primary structure and gene organisation of the 
Fraundorfer, C. Pieler, I. Fogy, and E. Kuechler. 1985. Human middle-component RNA of cowpea mosaic virus. EMBO J. 
rhinovirus 2: complete nucleotide sequence and proteolytic 2:941-946. 
processing signals in the capsid protein region. Nucleic Acids 31. Zabel, P., M. Moerman, G. Lomonossoff, M. Shanks, and K. 
Res. 13:2111-2126. Beyreuther. 1984. Cowpea mosaic virus VPg: sequencing of 
28. Stanway, G., P. J. Hughes, R. C. Mountford, P. D. Minor, and radiochemically modified protein allows mapping of the gene on 
J. W. Almond. 1984. The complete nucleotide sequence of a B-RNA. EMBO J. 3:1629-1634. 
44 
CHAPTER 4 
DETECTION OF A NOVEL PROTEIN ENCODED BY THE BOTTOM-COMPONENT 
RNA OF COWPEA MOSAIC VIRUS, USING ANTIBODIES RAISED AGAINST 
A SYNTHETIC PEPTIDE 
Joan Wellink, Martine Jaegle and Rob Goldbach 
Department of Molecular Biology, Agricultural University, 
De Dreijen 11, 6703 BC Wageningen, The Netherlands 
Journal of Virology, 61, 236-238 (1987) 
45 
JOURNAL OF VIROLOGY, Jan. 1987, p. 236-238 
0O22-538X/87/010236-03$02.0O/0 
Copyright © 1987, American Society for Microbiology 
Vol. 61, No. 1 
Detection of a Novel Protein Encoded by the Bottom-Component 
RNA of Cowpea Mosaic Virus, Using Antibodies Raised 
against a Synthetic Peptide 
JOAN WELLINK,* MARTINE JAEGLE, AND ROB GOLDBACH 
Department of Molecular Biology, Agricultural University, De Dreyen II, 6703 BC Wageningen, The Netherlands 
Received 4 June 1986/Accepted 22 September 1986 
A peptide was synthesized that corresponded to a sequence in the cowpea mosaic virus bottom-component 
RNA-encoded 200-kilodalton polyprotein showing homology to the picornaviral 3C proteases. By injecting a 
rabbit with this peptide, antibodies were obtained that allowed the detection of a novel viral protein derived 
from the 200-kilodalton polyprotein. This protein, which had a size of 24 kilodaltons was found in both infected 
cowpea leaves and cowpea protoplasts. 
Cowpea mosaic virus (CPMV) is a positive-strand RNA 
virus with a bipartite genome. Both RNAs are polyadenyl-
ated and have a small protein (VPg) linked to their 5' ends. 
The RNAs are translated into so-called polyproteins, which 
are posttranslationally cleaved to give the mature functional 
proteins (for a recent review, see reference 11). A detailed 
processing pathway of the 200-kilodalton (200K) polyprotein 
encoded by the bottom-component RNA (B-RNA) has been 
established (Fig. 1) by both in vitro translation studies (5,10, 
17) and in vivo observations (8, 9, 18). Except for the 24K 
polypeptide, all proteins included in Fig. 1 have been de-
tected in B-component-inoculated cowpea protoplasts by 
radioactive labeling and immunological methods (9, 18, 19). 
The 24K protein was included in the model since it could 
easily be generated by further cleavage of the 84K or 110K 
proteins (18). After the discovery of sequence homology 
b e t w e e n n o n s t r u c t u r a l p ro t e in s from CPMV and 
picornaviruses (6), the sequence of the putative 24K protein 
was found to exhibit homology to the picornaviral 3C 
proteases. These proteases have been found in infected host 
cells as stable products (12, 13, 15, 16). Hence, the CPMV 
24K protein could likewise be expected to occur as a stable 
protein, the existence of which had always escaped our 
attention. Moreover, the homology suggests that this protein 
may possess proteolytic activity. 
To demonstrate the existence of such a 24K protein in 
vivo, we decided to synthesize a peptide corresponding to 
part of this protein. A region was chosen that was well-
conserved among CPMV and the picornaviruses and repre-
sented the putative active site of the picornaviral proteases 
(1, 6). The peptide (Fig. 2) was synthesized by the solid-
phase method of Barany and Merrifield (2) and after purifi-
cation was characterized by amino acid analysis and high-
performance liquid chromatography (data not shown). It was 
injected in free form into a New Zealand white rabbit at 
14-day intervals (14a). Serum collected 8 days after the fifth 
injection showed a high titer against the peptide, as mea-
sured in an enzyme-linked immunosorbent assay (data not 
shown) and will be referred to in this paper as anti-24K 
serum. In a first experiment, cowpea protoplasts inoculated 
with only B components were analyzed for the presence of a 
24K protein, since B-RNA-encoded proteins are known to 
be overproduced in these cells by the absence of middle-
component RNA (M-RNA) (20). The protoplasts were la-
beled with [15S]methionine from 16 to 40 h after inoculation 
(18), and a 30,000 x g supernatant fraction (S30[7]) was 
prepared from these cells which was used for immunological 
analyses. With the anti-24K serum, a protein of approxi-
mately 24,000 daltons was precipitated (Fig. 3, lane 4) 
together with the B-RNA-ehcoded 170K, 110K, and 84K 
proteins, which are all known to contain the 24K protein 
sequence (Fig. 1). The preimmune serum only showed a faint 
reaction with the 170K and 110K proteins, probably due to 
nonspecific aggregation of these proteins (Fig. 3, lane 1). The 
specificity of the immunoreactions was confirmed by adding 
excess peptide (100 |xg) to the anti-24K serum prior to the 
immunoprecipitation. This pretreatment almost completely 
inhibited the precipitation of the 170K, 110K, 84K, and 24K 
proteins (Fig. 3, lane 5), To test whether the 24K protein was 
produced at the same time as the other viral proteins and 
whether it was a stable cleavage product, S30 fractions of 
protoplasts inoculated with B component or with complete 
virus (M + B) were prepared at different times after inocu-
lation. With these fractions, a protein blot was prepared 
which was subsequently incubated with anti-24K serum and 
125I-protein A as described previously (21). It was found 
(Fig. 4) that the 24K protein appeared at the same time after 
inoculation as the other viral proteins and that its concen-
(A)n 
VPg 
32 
B RNA (2.02x10e) 
I 
200 
I 
. 170 
58 VPg 24 
:
 Corresponding author. 
FIG. 1. Model for the proteolytic processing of the primary 
translation product of CPMV B-RNA. The RNA consists of 5,889 
nucleotides, excluding the poly(A) tail, and has a molecular weight 
of 2.02 x 106. VPg is indicated by a black box and all other 
polypeptides as lines. 
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FIG. 2. Location and amino acid sequence of the synthetic 
peptide. The amino acids, as predicted from the B-RNA sequence 
(14), are denoted by the single-letter code. Amino acids in this 
sequence corresponding to important constituents of the active site 
of the picornaviral 3C proteases (1) are underlined. The open 
reading frame of the B-RNA and the 200K (K) polyprotein are both 
indicated by white bands. The positions of the amino acids sur-
rounding the cleavage sites are indicated. 
inoculated w i t h - * B 
- 8 7 K 
~84k 
1 2 3 4 5 6 7 
+ excess 
peptide 
FIG. 3. Detection of the viral 24K protein in CPMV-infected 
cowpea protoplasts. The S30 supernatant fractions were prepared 
from protoplasts inoculated with B components (B) or complete 
virus (B + M) or uninoculated (7). Immunoprecipitations of these 
fractions were carried out with preimmune serum (PI) (lane 1), 
anti-24K serum (lanes 2 to 5), anti-VPg serum (lane 6), or anti-170K 
serum (lane 7) as described previously (4, 7). The immunoprecipi-
tates were analyzed on a 12.5% Polyacrylamide gel. For the immu-
noprecipitation shown in lane 5, 5 jxl of anti-24K serum was 
pretreated with 100 fig of peptide for 3 h at 4°C in phosphate-
buffered saline-TDS (4). Antiserum against VPg was prepared as 
described previously (21). This serum also reacted with both capsid 
proteins, which contaminated the VPg preparation used for immu-
FIG. 4. Time course experiment with cowpea protoplasts inocu-
lated with CPMV components. S30 fractions of cowpea protoplasts 
inoculated with complete virus (M + B) or with B components alone 
(B) were prepared at different times after inoculation as indicated at 
the top. After electrophoresis in a Polyacrylamide gel, the fractions 
were blotted onto nitrocellulose, and the resulting blot was subse-
quently incubated with anti-24K serum and 125I-protein A. Sizes are 
indicated in kijodaltons (K). 
tration remained low. The stability of the 24K protein was 
approximately similar to that of the 84K protein, and it did 
not accumulate with time. 
To test whether this 24K protein was also detectable in 
intact infected cowpea leaves, a protein blot was made 
containing cytoplasmic and membrane fractions from in-
fected and noninfected leaves prepared as described in detail 
previously (3). Treatment of this blot with anti-24K serum 
and 123I-protein A revealed that the 24K protein was detect-
ably synthesized in cowpea leaves, being present mainly in 
the cytoplasmic fraction (Fig. 5, lane 5). A competition 
experiment with excess peptide again demonstrated the 
specificity of the reaction of the 24K, 84K, 110K, and 170K 
proteins with the anti-24K serum (data not shown). 
Clearly, by using antibodies raised against a synthetic 
peptide, we were able to detect a novel viral protein in 
CPMV-infected protoplasts and leaves. This protein, which 
has a size of 24,000 daltons, has not been detected before 
and formed a "gap" in our processing model of the 200K 
polyprotein (Fig. 1). This protein is of particular interest 
since it shows sequence homology to the picornaviral 3C 
proteases (1, 6) and therefore probably also represents a 
protease. Indeed, in vitro translation experiments in which 
transcripts of modified cDNA clones of B-RNA were used, 
indicate that the 24K protein is involved in the cleavage of at 
least one glutamine-serine and two glutamine-glycine 
proteolytic cleavage sites in the CPMV polyproteins (J. 
Verver, R. Goldbach, J. A. Garcia and P. Vos, manuscript in 
preparation). It will be of interest to test whether the 24K 
nization of rabbits (21). Antiserum against the 170K protein was 
prepared as described previously (7) and showed affinity for the 
170K, 110K, and 87K proteins. Sizes are indicated in kilodaltons (K). 
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FIG. 5. Detection of the 24K protein in CPMV-infected cowpea 
leaves. Cytoplasmic (cyt) and membrane (mem) fractions from 
cowpea leaves were isolated as described before (3). These frac-
tions, together with S30 fractions from cowpea protoplasts, were 
run on a Polyacrylamide gel, blotted onto nitrocellulose, and probed 
with anti-24K serum (see the legend to Fig. 4). Lanes 2, 3, and 4 
contain S30 fractions from uninoculated, B-, and B + M-inoculated 
protoplasts, respectively. Lanes 5 and 6 contain cytoplasmic and 
membrane fractions from infected leaves; lanes 7 and 8 contain 
similar fractions from uninfected leaves. Lane 1 contains an S30 
fraction of [35S]methionine-labeled CPMV-infected protoplasts. 
Sizes are indicated in kilodaltons (K). 
protein in its free form has enzymatic activity or whether 
only precursor proteins containing its sequence (i.e., the 
200K, 170K, 110K, and 84K proteins, see Fig. 1) are 
involved in proteolytic cleavage reactions. 
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The function of the 24-kilodalton (24K) protein encoded by cowpea mosaic virus (CPMV) has been studied by con-
structing a bacterial expression plasmid that contained a cloned chimeric segment consisting of partial DNA copies 
of CPMV M-RNA (including sequences coding for both capsid proteins) and B-RNA (including sequences coding for 
the 24K protein). Viral sequences were transcribed from the phage T7 promoter </>10 of plasmid pT7-6 using T7-RNA 
polymerase expressed from plasmid pGP1-2 present in the same cells. Upon inducing the synthesis of T7-RNA poly-
merase several new polypeptides that contained CPMV-specific sequences were expressed, as demonstrated by 
immunoprecipitation and immunoblotting. Furthermore a proteolytic activity was detected in induced cells which cleaved 
the viral protein sequences specifically at two glutamine-glycine sites. One of the cleavage products represented 
capsid protein VP23. The proteolytic activity was absent when an 87-bp deletion was introduced in the coding region 
for the 24K protein, indicating that this protein represented the protease involved in the proteolytic processing at 
those Specific sites. © 1987 Academic Press, Inc. 
INTRODUCTION 
Cowpea mosaic virus (CPMV), the type member of 
the comoviruses, has a bipartite genome consisting of 
two separately encapsidated plus-stranded RNA mol-
ecules which possess a genome-linked protein (VPg) 
at their 5'-terminus and are polyadenylated (El Manna 
and Bruening, 1973; Daubert ef al., 1978; Stanley ef 
al., 1978). Both RNAs are translated into large poly-
peptides from which the functional proteins are derived 
by proteolytic cleavages (for a recent review, see Gold-
bach and Van Kammen, 1985). The larger of the two 
genomic RNAs, the B-RNA (5889 nucleotides; Lomo-
nossoff and Shanks, 1983) is translated into a 200-
kilodalton (200K) polyprotein which is first cleaved to 
give 32K and 170K polypeptides (Pelham, 1979; Gold-
bach ef al., 1981). The 170K polypeptide is then further 
cleaved following two different pathways to give four 
final cleavage products in the order NH2-58K-VPg-24K-
87K-COOH (see Fig. 1 and Rezelman ef al., 1980; 
Goldbach ef al., 1982; Wellink ef a/., 1987). Thesmalier 
of the two RNAs, the M-RNA (3481 nucleotides; Van 
Wezenbeek ef al., 1983) is translated in vitro into two 
polypeptides of 95K and 105K with overlapping amino 
acid sequences (Pelham, 1979; Franssenefa/., 1982). 
These polypeptides are proteolytically cleaved at the 
same position to give two polypeptides of 58K and 48K, 
derived from the amino-terminal parts of the polypro-
1
 Present address: Centra de Biologia Molecular (CSIC-UAM), 
Universidad Autonoma, Canto Blanco, 28049 Madrid, Spain. 
2
 To whom requests for reprints should be addressed. 
teins, together with a 60K polypeptide which represents 
the precursor to both capsid proteins VP37 and VP23 
(Fig. 1). 
The proteolytic cleavages by which the M- and B-
RNA-encoded polyproteins are processed occur be-
tween three different dipeptide sequences, i.e., be-
tween glutamine-methionine, glutamine-serine, and 
glutamine-glycine residues (Fig. 1 and Wellink et al., 
1986). The 32K protein, the amino-terminal cleavage 
product from the 200K polyprotein encoded by the B-
RNA, has been proposed by Franssen ef al. ( 1984b) to 
represent the protease involved in the cleavage at the 
glutamine-methionine site in the M-RNA-encoded 
105K and 95K polyproteins (Fig. 1 ). Recently, evidence 
has been obtained that the 24K protein, also encoded 
by the B-RNA, represents a second protease, respon-
sible for the primary cleavage (at a glutamine-serine 
site) in the 200K polyprotein which gives rise to the 
32K and 170K proteins (Verver ef al., 1987). This con-
clusion is supported by the observation that the 24K 
protein shows amino acid sequence homology to the 
picomaviral 3C proteins (Franssen ef al., 1984a) in-
volved in the proteolytic processing of the polyproteins 
encoded by these viruses. 
In this report we describe the expression in Esche-
richia coli of a chimeric cDNA segment consisting of 
both CPMV M- and B-RNA-specific sequences, by us-
ing the phage T7 promoter-RNA polymerase binary 
system described by Tabor and Richardson (1985). 
Following this approach we have been able to show 
that the CPMV B-RNA-encoded 24K protein can be 
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produced in E. coli as an active protease. The experi-
ments presented show that this protease is responsible 
for the proteolytic cleavages at the two glutamine-gly-
cine sites present in the CPMV polyproteins. One of 
the cleavage products released by the protease rep-
resents the capsid protein VP23. 
MATERIALS AND METHODS 
Bacterial strains and plasmids 
E. coli strain JM109 (Yanish-Perron ef a/., 1985) was 
used during the construction of the expression plas-
mids. E. coli strain K38 (Rüssel and Model, 1984) was 
used for all expression experiments. Plasmid pT7-6, 
related to pT7-1 {Tabor and Richardson, 1985), was a 
kind gift of S. Tabor. Plasmid pGP1-2 has been de-
scribed by Tabor and Richardson (1985), plasmids 
pSPMB401 and pSPMB373 by Vos ef al. (manuscript 
in preparation), plasmid plNIII103ompA2 by Ghrayeb ef 
al. (1984), and pUC8 by Vieira and Messing (1982). 
The construction of the plasmids pTMBAI and 
pTMBAId is described under Results. All DNA manip-
ulations were essentially as described by Maniatis ef 
al. (1982). 
Labeling of proteins 
£ coli K38 cells, harboring the different expression 
plasmids, were grown at 30° in Luria broth containing 
50 jjg/ml ampicillin and kanamycin to A5S0 = 0.5. A 
sample of 0.2 ml was collected by centrifugation and 
the cell pellet was washed once with 1 ml of M9 me-
dium and resuspended in 1 ml of the same medium 
supplemented with 20 tig/m\ thiamine and 0.01% 
amino acid mixture (minus cysteine and methionine). 
After a 60-min incubation at 30° the temperature was 
shifted to 43° for 15 min (at this temperature the cl857 
repressor, which controls the expression of the T7 RNA 
polymerase, is inactivated). Rifampicin (Sigma, St. 
Louis) was added to a final concentration of 400 pg/ 
ml and the incubation was continued for an additional 
10 min. The temperature was then lowered to 30° and 
20 min later 10 pCi of [35S]methionine (1050 Ci/mmol, 
NEN, Boston) was added. After 5 min of labeling the 
cells were collected by centrifugation, resuspended in 
120 p\ of sample buffer (10 m/W Tris-HCI, pH 8.0, 1 
m/W EDTA, 10% glycerol, 2% SDS, 5% /3-mercapto-
ethanol and 0.001% bromphenol blue), and boiled for 
2 min. Aliquots were either directly analyzed by SDS-
polyacrylamide gel electrophoresis or first subjected to 
immunoprecipitation. 
Pulse-chase labeling of proteins 
For pulse-chase analysis £ coli cells were treated 
as described above, except that cells were pulse la-
beled with [35S]methionine for only 1 min, followed by 
a chase with excess nonlabeled methionine (1 mg/ml). 
Samples were collected at different times, adjusted to 
20 m/W sodium phosphate, pH 7.0, 1% formaldehyde, 
and 1 mg/ml methionine, and placed on ice. The prep-
aration of bacterial extracts suitable for immunological 
analysis was as described above. 
Accumulation of proteins in E. coli 
Cells were grown in enriched medium (2% tryptone, 
1% yeast extract, 0.5% NaCI, 0.2% glycerol, 50 m/W 
potassium phosphate, pH 7.2, 50 jtg/ml ampicillin and 
kanamycin) at 30°. At an A590 of 0.6, the temperature 
was raised to 42° for 25 min. After this period rifampicin 
was added to a final concentration of 100 /ug/rnl and 
the temperature was shifted to 37°. Cells were har-
vested at desired times and prepared for analysis on 
SDS-polyacrylamide gels as described above. 
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Immunological methods 
Cell pellets were prepared for immunological analysis 
by boiling in 120 pi of sample buffer. Aliquots of 30 pi 
were diluted to 500 /xl in TNETDS (50 m/W Tris-HCI, 
pH7.5, 150mMNaCI, 5 mM EDTA, 1% Triton X-100, 
0.5% DOC, 0.1% SDS) and immunoprecipitations were 
carried out on these samples as described previously 
(Franssen ef a/., 1984b). Precipitates obtained were 
analyzed on SDS-polyacrylamide gels. Western blots 
of bacterial extracts, electrophoresed in 12.5% Poly-
acrylamide gels, were prepared and subsequently in-
cubated with antiserum and '26l-protein A as has been 
described before (Zabel et al., 1982). 
RESULTS 
Construction of Plasmids pTMBAI and pTMBAId 
The construction of the Plasmids pTMBAI and 
pTMBAId is schematically shown in Fig. 2. A fragment 
containing both an M-RNA-specific cDNA sequence 
(from nucleotide 1446 to nucleotide 3496 of M-RNA) 
and a B-RNA-specific cDNA sequence (from nucleotide 
2820 to nucleotide 3865 of B-RNA) was obtained by 
digestion of plasmid pSPMB401 (Fig. 2 and Vos et al., 
manuscript in preparation) with SsmHI (partially) and 
EcoRI. After the sticky ends were filled in using Klenow 
fragment of E. coli DNA polymerase I, this 3-kb fragment 
was inserted in the Smal site of pUC8, resulting in 
pU410. This plasmid was digested with Bam\-\\ (par-
tially) and £coRI and the 3-kb fragment thus released 
inserted in plNIII"3ompA2 (Ghrayeb et ai, 1984), pre-
viously linearized with BamHl and fcoRI. Thus, plasmid 
pompA2MB349 was obtained, in which the chimeric 
virial cDNA segment, fused to the sequence coding 
for the signal peptide of the E. coli OmpA protein, was 
under the control of Lpp/Lac promoters (Grahyeb ef 
a/., 1984). As synthesis of CPMV-induced polypeptides 
could not be detected in £ coli harboring this plasmid 
either by labeling with [35S]methionine or Western blot-
ting (results not shown), we decided to make use of 
the T7-RNA polymerase/promoter system (Tabor and 
Richardson, 1985) which combines high level expres-
sion from the T7 010 promoter with very low back-
ground synthesis of bacterial proteins. Hence, plasmid 
pompA2MB349 was digested withXbal, which cleaved 
between the Lpp/Lac promoters and the OmpA signal 
sequence (Ghrayeb et ai, 1984), and with BamH\ (par-
tial), and the 3.1-kb fragment containing the chimeric 
cDNA sequence was inserted in the polylinker region 
of plasmid pT7-6 (S. Tabor, unpublished). The resulting 
plasmid was called pTMBAI. Plasmid pTMBAId was 
constructed by exchanging the 740-bp Kpn\-BamH\ 
fragment (from nucleotide 3138 to 3857 in the B-RNA 
sequence) of pTMBAI by the equivalent Kpn\-BamH\ 
EcoR I 
(partial) BamH I 
EcoR I 
(partial) BamH 1 
XOa I 
(partial) BarrtH I 
Kpnl 
(partial) BamH I 
FIG. 2. Construction of the expression Plasmids pTMBAI and 
pTMBAI d. For details of the construction see the text. Complemen-
tary DNA sequences derived from viral M- and B-RNA are indicated 
by white bars and cDNA sequences derived from B-RNA by hatched 
bars. The 24K protein is encoded by the B-RNA from nucleotide 
3048 to nucleotide 3672. The SP6 promoter and the T7 010 promoter 
are indicated with black boxes and the OmpA signal sequence with 
a dotted box. Next to plasmid pSPBM373 the Sau3A fragment, de-
leted in this plasmid, is shown. Only relevant restriction sites are 
shown: B = BamHl, E = EcoRI, H = Hindi», K = Kpn\, S = Sau3A, 
and Xb = Xba\. 
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FIG. 3. Expression of plasmid pTMBAI in E. coli. Bacteria harboring 
different plasmid combinations were either not induced (lanes 1, 4, 
7) or induced in the absence (lanes 2, 5, 8) or presence (lanes 3, 6, 
9) of rifampicin and labeled with [35S]methionine for 5 min. Bacterial 
pellets were boiled in sample buffer and the extracts were analyzed 
on a 12.5% Polyacrylamide gel containing SDS. Lanes 1, 2. and 3 
contain extracts of cells harboring only pGP1-2, lanes 4, 5, and 6 
extracts of cells harboring pGP1-2 and pT7-6, and lanes 7, 8, and 9 
extracts of cells harboring pGP1-2 and pTMBAI. 
fragment from pSPMB373 (Vos et al., manuscript in 
preparation) in which an 87-bp Sau3A fragment (from 
nucleotide 3240 to 3327 in the B-RNA sequence) was 
deleted as has been described in detail elsewhere (Fig. 
2, Verver ef ai, 1987). 
Expression of CPMV-specific sequences from 
plasmid pTMBAI 
Plasmid pTMBAI was introduced into the E. coli 
strain K38 harboring plasmid pGP1-2 which contained 
the gene for the T7 RNA polymerase under the control 
of the XPL promoter (Tabor and Richardson, 1985). Af-
ter induction of the T7 RNA polymerase by raising the 
temperature to 43° and addition of rifampicin, the bac-
terial proteins were labeled with [35S]methionine for 5 
min (see Materials and Methods). Bacterial extracts 
were prepared, and labeled proteins were subjected 
to analysis on a SDS-polyacrylamide gel (Fig. 3). In the 
presence of rifampicin, the synthesis of proteins by 
heat-induced bacteria containing pGP1-2 or pGP1-2 
and pT7-6 decreased dramatically (Fig. 3, lanes 3 and 
6). On the other hand, under these conditions several 
labeled polypeptides were synthesized in cells con-
taining both pTMBAI and pGP1-2 (Fig. 3, lane 9). Im-
munoprecipitation of the induced proteins demon-
strated their viral nature. Anti-VP23 serum precipitated 
polypeptides of 105K, 90K, and 70K and a polypeptide 
with the same mobility as the mature capsid protein 
VP23 (Fig. 4, lanes 3 and 7). Anti-VP37 serum also 
immunoreacted with the 105K, 90K, and 70K proteins 
but a polypeptide with the size of capsid protein VP37 
was not detected (Fig. 4, lanes 4 and 8). Antiserum 
against the B-RNA-encoded 24K protein precipitated 
the 105K and 90K products as well as 35K, 33K, and 
20K polypeptides, whereas anti-VPg serum recognized 
the 105K, 35K, and 33K proteins (Fig. 4, lanes 5 
and 6). 
Pulse-chase analysis 
The results presented above suggested that, in cells 
harboring plasmid pTMBAI, viral polypeptides were 
synthesized, which were proteolytically processed to 
produce a series of smaller products. To verify this as-
sumption, pulse-chase experiments were performed. 
Heat-induced cultures of bacteria containing the Plas-
mids pGP1-2 and pTMBAI were labeled for 1 min with 
[36S]methionine in the presence of rifampicin and then 
chased by adding an excess of unlabeled methionine. 
Samples removed after different chase periods were 
subjected to immunoprecipitation using several anti-
sera and analyzed on SDS-polyacrylamide gels. 
The analyses indicated that'the polypeptides of 105K 
and 90K, immunoprecipitable with both anti-VP23 and 
anti-24K serum, represented primary translation prod-
ucts from pTMBAI. The amount of these products rap-
CPMV-infected 
protoplasts 
-VP23 
- 20k 
1 2 3 4 5 6 7 8 
FIG. 4. Immunological analysis of polypeptides expressed from 
plasmid pTMBAI. Extracts of cells harboring both pGP1-2 and 
pTMBAI were prepared after induction in the presence of rifampicin 
and labeling for 5 min with [35S]methionine. After immunoprecipitating 
aliquots with different antisera the precipitates obtained were analyzed 
on a 12.5% Polyacrylamide gel containing SDS (lanes 5 to 8). As a 
control, immunoprecipitations were carried out on [36S]methionine-
labeled, CPMV-infected cowpea protoplast fractions using the same 
antisera (lanes 1 to 4). Antisera used are indicated above each lane. 
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FIG. 5. Pulse-chase analysis of polypeptides expressed from pTMBAI or pTMBAId. E. coli cells were induced in the presence of rjfampicin 
and labeled with [35S]methionine for 1 min followed by a chase with unlabeled methionine. Extracts from bacteria containing pTMBAI and 
pGP1-2 (lanes 1 to 5 and lanes 9 to 13) or pTMBAId and pGP1-2 (lanes 6 to 8 and lanes 14 to 16) were subjected to immunoprecipitation 
using anti-VP23 serum (lanes 1 to 8) or anti-24K serum (lanes 9 to 16) and the precipitates were analyzed on a 12.59b Polyacrylamide gel 
containing SDS. The chase times are indicated at the top of the figure. The positions of molecular weight markers in the gels are indicated in 
the center of the figure. The origin of the 30K protein that appeared in these experiments as a minor processing product from the polyproteins 
expressed from pTMBAI was not determined. 
idly decreased after 15 min of chase, while at the same 
time the amounts of 70K protein, reactive with anti-
VP23 serum, and the 35K protein, reactive with anti-
24K serum, increased (Fig. 5, lanes 1-4 and 9-13), 
indicating that proteolytic processing occurred in these 
cells. After longer chase periods the amount of free 
VP23 increased considerably (Fig. 5, lanes 1-4), 
whereas some decrease in intensity of the 70K band 
after longer chase periods was observed. The 33K, 
30K, and 20K proteins, which all immunoprecipitated 
with anti-24K serum, appeared after 15 min of chase 
(Fig. 5, lanes 9-13). 
The disappearance of the 105K and 90K proteins 
and the simultaneous appearance of the smaller prod-
ucts unequivocally demonstrate that two primary 
translation products (105K and 90K), which undergo 
proteolytic processing, are expressed from pTMBAI. 
Effect of a deletion of 87 nucleotides in the coding 
sequence of the 24K protein on 
proteolytic processing 
Previous experiments have indicated that the 24K 
polypeptide is the protease which cleaves at a gluta-
mine-serine site in the 200K primary translation product 
of B-RNA, thus giving rise to the 32K and 170K poly-
peptides (Verver et al., 1987; see also Fig. 1). To test 
whether this 24K polypeptide is also responsible for 
the proteolytic activity detected in £ coli cells harboring 
Plasmid pTMBAI, we constructed plasmid pTMBAId 
which was similar to pTMBAI but contained a small 
deletion of 87 nucleotides in the coding region for this 
protein. Bacteria containing this plasmid and pGP1-
were subjected to pulse-chase analysis as described 
above. This resulted in the detection of two polypep-
tides of 100K and 85K which run slightly faster in SDS-
polyacrylamide gels than the 105K and 90K proteins, 
respectively, produced in cells harboring plasmid 
pTMBAI (Fig. 5, lanes 6-8 and 14-16). These differ-
ences in size are in agreement with the deletion intro-
duced in the open reading frame from pTMBAId. After 
longer chase periods the amounts of both polypeptides 
decreased, indicating some degradation (Fig. 5, lanes 
8 and 16). However, no distinct smaller products ap-
peared, demonstrating that the specific proteolytic ac-
tivity was eliminated by the small deletion in the 24K 
protein coding region. 
Accumulation of CPMV-specific polypeptides in 
E. coli as detected by immunoblotting 
To analyze the stability and possible accumulation 
of the CPMV-specific polypeptides detected in £ coli, 
bacteria harboring plasmids pGP1-2 and pTMBAI or 
pTMBAId were grown in enriched medium, heat-in-
duced, and subsequently cultured in the presence of 
rifampicin. At different times after heat induction, sam-
ples were collected and subjected to SDS-polyacryl-
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' FIG. 6. Accumulation of CPMV-specific polypeptides in E. coli. 
Bacteria were grown in enriched medium, induced in the presence 
of rifampicin, and collected at different times after induction, as in-
dicated at the top of the figure. Extracts from cells containing pTMBAI 
and pGP1-2 (lanes 1 to 6) or pTMBAId and pGP1-2 (lanes 7 to 12) 
were separated in a 12.5% Polyacrylamide gel containing SDS, blotted 
onto nitrocellulose, and probed with anti-VP23 serum and 125l-protein 
A. A cytoplasmic fraction of CPMV-infected cowpea leaves was run 
as a marker in the same gel (lane 13). 
amide gel electrophoresis. The separated proteins were 
blotted onto nitrocellulose paper and screened with 
anti-VP23 serum for the presence of mature capsid 
protein VP23. Protein VP23 could be detected 30 min 
after heat induction and increasing amounts were found 
after longer periods of incubation (Fig. 6). Two and three 
hours after heat induction the major CPMV products 
were the 70K protein (see Fig. 6) and 35K and 33K 
proteins (as detected with anti-24K serum, data not 
shown). Although these data indicate a reasonable 
stability of the various polypeptides derived upon pro-
teolytic processing from the primary translation product 
from pTMBAI, their amounts were too low to be vi-
sualized by Coomassie brilliant blue staining (data not 
shown). In extracts of cells containing the plasmid 
pTMBAId only the 100K and 85K proteins could be 
detected, confirming the effect of the deletion in the 
24K protein in abolishing the proteolytic activity (Fig. 
6, lanes 7-12). 
DISCUSSION 
Using the binary T7 expression system (Tabor and 
Richardson, 1985) we have been able to express in £ 
coli cells a chimeric cDNA construct (pTMBAI) con-
taining sequences derived from both CPMV B- and M-
RNA under control of the T7 promoter </>10. Upon in-
duction of the T7 RNA polymerase, long precursor pro-
teins were produced which enabled us to study the 
activity and specificity of the 24K protease of CPMV, 
residing in the precursor. 
After heat induction, bacteria harboring plasmid 
pGP1-2 (supplying the T7 RNA polymerase) and plas-
mid pTMBAI produced a 105K polypeptide that cor-
responded to the full coding capacity of the CPMV-
specific cDNA segment in pTMBAI (Fig. 7; this poly-
peptide should not be confused with the 105K protein 
encoded by CPMV M-RNA that is shown in Fig. 1). In 
addition a second large polypeptide of 90K was de-
tected which in contrast to the 105K protein did not 
react with anti-VPg serum. Since the region coding for 
VPg is located at the 5' end of the chimeric cDNA insert 
of pTMBAI (see Fig. 7), and since it appeared con-
currently with the 105K protein in pulse-chase exper-
iments, the 90K polypeptide may have originated from 
an internal intiation site, possibly at nucleotide 3210 of 
the B-RNA sequence, where a Shine- and Dalgarno-
like sequence is found between nucleotides 3201 and 
3205 (GGA, see Lomonossoff and Shanks, 1983). This 
idea is further supported by the finding that expression 
of pTMBAId resulted in the production of a similar 
second product (of 80K) which, in view of the presence 
of a deletion in the 24K protease coding region in this 
plasmid, was very unlikely to be a proteolytic processing 
product (see later). Pulse-chase experiments and im-
munological analysis showed that the primary products 
from pTBMAI were cleaved giving rise to a 70K protein, 
corresponding to the carboxy-terminal part of the 90K 
and 105K polypeptides (since it precipitated with anti-
VP23 and anti-VP37 serum) and to several small pep-
tides corresponding to the amino-terminal portion of 
these proteins. The 35K polypeptide which reacted with 
both anti-24K and anti-VPg serum probably corre-
sponded to the amino-terminus of the 105K polypep-
tide, while the 20K polypeptide, reactive only to anti-
24K serum, most likely corresponded to the amino-
terminal part ofthe90K protein (see Fig. 7). Furthermore 
a protein comigrating with the capsid protein VP23 and 
reactive with anti-VP23 serum was found in bacteria 
harboring pTMBAI. 
In £ coli cells harboring plasmid pTMBAId contain-
ing a small deletion in the 24K protein coding region, 
the proteolytic activity was completely abolished and 
only high-molecular-weight polypeptides (of 100K and 
85K) could be detected (Fig. 5, lanes 6-8 and 14-16). 
This finding demonstrates that the 24K protein repre-
sents the protease responsible for the cleavages in the 
viral proteins produced in cells carrying pTMBAI. 
The occurrence in bacteria harboring pTMBAI of the 
70K, 35K, 33K, and 20K proteins indicates that the 
105K and 90K proteins are proteolytically cleaved at 
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FIG. 7. Model for the processing of polypeptides expressed from pTMBAI in E. coli. The CPMV-specific cDNA fragment in pTMBAI is 
represented by a white bar with the relevant viral protein-coding regions and the position of the Sau3A fragment deleted in pTMBAI d indicated. 
Polypeptides are indicated by single lines. The dotted line at the N-terminus of the 90K protein illustrates that this N-terminus is not precisely 
known. The presence of the OmpA signal sequence at the N-termini of the 105K and 35K proteins was not analyzed. The 47K protein is 
represented as a broken line, since this protein was found in very low amounts. Cleavage sites are indicated by A, Gln-Ser, A, Gln-Gly, and 
A, Gin-Met. 
the glutamine-glycine dipeptide cleavage site at the 
right border of the 24K protein (see Fig. 7). We have 
not been able to determine whether this cleavage oc-
curred intra- or intermolecularly. In vitro translation ex-
periments with B-RNA seem to indicate that the cor-
responding cleavage reaction in the 170K protein (see 
Fig. 1) is intramolecular (Peng and Shih, 1984). In view 
of the efficiency of the reaction this could also be the 
case in the artificial protein expressed from pTMBAI. 
The fate of the OmpA protein signal peptide in the chi-
meric viral polypeptides has not been analyzed, but the 
detection of a 33K protein immunoprecipitable with 
both anti-24K and anti-VPg serum suggests that prob-
ably this signal peptide sequence (of 22 amino acids) 
was removed from some of the 35K polypeptides. This 
would also agree with the observation that the 33K 
protein is the only protein detectable in the periplasmic 
space, the signal sequence being removed during 
transport (data not shown). 
We have obtained direct evidence of cleavage at the 
glutamine-glycine site that is used to separate the 
capsid proteins from each other by detecting free VP23 
both by immunoprecipitation and Western blotting. The 
results do not allow us to conclude whether VP23 is 
directly cleaved from the primary translation products 
from pTMBAI or from the 70K intermediate (Fig. 7). 
The observation that the 70K protein appeared in 
pulse-chase experiments prior to VP23 and the in-
crease of VP23 at chase times in which the amount of 
the 70K product remained constant suggests that the 
primary translation, proteins are first cleaved into the 
35K and 70K polypeptides and that VP23 is subse-
quently released from the. 70K product. Thus this 
cleavage most likely occurs intermolecularly as is also 
the case upon expression of the natural RNAs of CPMV 
(Goldbach and Van Kammen, 1985). Immunological 
detection of the amino-terminal counterparts of this 
cleavage reaction proved to be difficult. With anti-VP37 
serum only a small amount of a 47K protein was de-
tected (Fig. 4, lane 8) that, possibly because of its hybrid 
nature, was highly unstable in E. coli. 
In a previous report we have presented evidence that 
the 32K protein encoded by B-RNA also represents a 
protease that cleaves at a glutamine-methionine pair 
in the two M-RNA-encoded polyproteins thus giving 
rise to the 58K and 48K polypeptides together with a 
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60K precursor to the capsid proteins VP23 and VP37 
(Fig. 1, Frgnssen et ai, 1984b). The chimeric protein 
expressed from the cDNA segment present in the 
Plasmid pTMBAI contains this glutamine-methionine 
dipeptide and, additionally, a similar cleavage site at 
the left border of the 24K protein (Fig. 7). Cleavage at 
both these sites could not be detected in the experi-
ments described in this paper, which is in agreement 
with our previous results. 
It has been reported that the 24K protease cleaves 
the B-RNA-encoded 200K polyprotein at the glutamine-
serine site by which the 32K and 170K proteins are 
released (Verver et ai, 1987). Cleavage at the gluta-
mine-serine site bordering the left side of the VPg se-
quence in the CPMV fusion protein expressed from 
pTMBAI was not observed. This result is in agreement 
with the fact that synthesis of free VPg has never been 
detected in vivo or in vitro. A possible explanation could 
be that the cleavage at this glutamine-serine site 
(probably catalyzed by the 24K protease) can only take 
place in close association with the linkage of VPg to 
the 5' end of the RNA during RNA replication (Jaegle ef 
a/., 1987). 
For poliovirus two virus-encoded proteases have also 
been described (Hanecak et al., 1982; Toyoda et al., 
1986). Both proteins showed specific proteolytic activ-
ity when they were produced by expression of their 
coding regions in E. coli (Hanecak et ai, 1984; Toyoda 
ef a/., 1986). Since protease 3C of poliovirus shows 
sequence homology to the 24K protease of CPMV 
(Franssen et ai, 1984) and both recognize glutamine-
glycine sites (Hanecak et ai, 1982; this paper), these 
. two proteases may be functionally closely related. 
Thirteen glutamine-glycine and 9 glutamine-serine 
sites are present in the CPMV polyproteins, while only 
two of each group are recognized by the 24K protease. 
The ability of this protein to be functional in a bacterial 
system and to be able to recognize genuine cleavage 
sites in artificial precursor proteins very different in size 
and structure from the natural substrates will permit 
the study of the structural requirements around the 
cleavage sites by mutagenesis of these protein pre-
cursors. 
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SUMMARY 
Upon infection of cowpea mesophyll protoplasts with cowpea mosaic virus (CPM V), 
the only M RNA-encoded proteins detected so far have been the two capsid proteins 
VP37 and VP23. We now report the detection of a M, 60000 (60K) precursor to both 
capsid proteins in infected protoplasts cultured in the pressence of zinc ions. 
Furthermore a M RNA-encoded 48K protein was detected in the membrane fraction 
of infected cells using antisera raised against synthetic peptides. The results obtained 
indicate that, just like the bottom component RNA, the M RNA of CPMV is 
translated in vivo into a polyprotein from which proteins are derived by proteolytic 
cleavage. 
INTRODUCTION 
The genome of cowpea mosaic virus (CPMV) consists of two polyadenylated plus-strand 
RN As which are separately encapsidated. Previous studies on the viral proteins encoded by the 
larger bottom (B) component RNA, 5889 nucleotides long excluding the poly(A) tail 
(Lomonossoff & Shanks, 1983), have revealed that the expression of this RNA involves 
translation into a M, 200000 (200K) polyprotein which upon proteolytic processing gives rise to 
six final cleavage products (for a recent review, see Goldbach & Van Kammen, 1985). The 
expression of the smaller middle (M) component RNA, 3481 nucleotides long excluding the 
poly(A) tail (Van Wezenbeek et al., 1983), is less well understood. Although a translation model 
for this RNA has been proposed, this model (Fig. 1) is almost entirely based on translation 
studies in vitro. 
In both the wheat germ system and rabbit reticulocyte lysates, M RNA is translated into two 
overlapping proteins of I05K and 95K (Pelham, 1979; Franssen et al, 1982), the 105K protein 
being initiated at an A U G codon at position 161 and the 95K protein at an AUG codon at 
posit ion512and/or524(Vose(a/ ' . , 1984; Van Wezenbeek et ai, 1983). Both primary translation 
products are processed by a B RNA-encoded protease to give 58K and 48K proteins 
respectively, together with a 60K precursor to both capsid proteins VP37 and VP23 (Fig. 1 ; 
Pelham, 1979; Franssen et al., 1982, 1984). All attempts to achieve cleavage of the 60K 
precursor into mature capsid proteins have so far failed. Since the mature capsid proteins are the 
only M RNA-encoded proteins detected in infected cells (Goldbach et al, 1980) it is not known 
whether the translation model presented in Fig. 1 is also valid in vivo. In this paper we report the 
occurrence of a 60K capsid precursor protein and an M RNA-encoded 48K protein in CPMV-
infected cells. These results definitely show that the M R N A is also expressed in vivo by 
polyprotein processing. 
METHODS 
Virus and plants. CPMV (Sb isolate) was propagated in cowpea plants (Vigna unguiculata L. 'California 
Blackeye') as described by Klootwijk et al. (1977) and Van Kammen (1967), and B and M components were 
purified as described by Rezelman et al. (1980). 
t Present address: Plant Breeding Institute, Maris Lane, Trumpington, Cambridge CB2 2LQ, U.K. 
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Inoculation of protoplasts and labelling of proteins. Mesophyll protoplasts were prepared from 10-day-old primary 
cowpea leaves and inoculated and incubated as described by Rezelman el ul. (1980). When labelled proteins were 
required, protoplasts were supplied with P'Sjmethionine (1000 Ci/mmol : New England Nuclear) as described by 
Franssen et al. (1984). Protoplasts were collected by centrifugation and frozen. Frozen pellets, corresponding to 
portions of 106 protoplasts, were resuspended in 100 u.1 of HB buffer (50 mM-Tris-acelate pH 8 2,10 mM-potassium 
acetate, 1 mM-EDTA, 5 mM-dithioerythritol, 1 mM-phenylmethylsulphonyl fluoride, 10% sucrose) and centrifuged 
at 4 °C for 30 min at 30000g yielding a supernatant (S30) fraction and a pellet fraction. In some cases the medium 
in which the protoplasts had been incubated was also analysed. 
Fractionation of cowpea leaves. CPMV-infected and non-infected cowpea leaves were fractionated into nuclear, 
membrane and cytoplasmic fractions, as described by Zabel et al. (1982). 
Preparation of antiserum against synthetic peptides. Two peptides (of nine and 30 amino acids) were synthesized 
by the solid-phase method (Barany & Merrifield, 1980). The peptides were characterized by amino acid analyses 
and high performance liquid chromatography. The shorter peptide, peptide S, was coupled to keyhole limpet 
haemocyanin using glutaraldehyde (Baron & Baltimore, 1982), and the longer peptide, peptide L, was not coupled 
to a carrier protein. To obtain monospecific antibodies the coupled peptide S and free peptide L were injected into 
New Zealand white rabbits at 14 day intervals (Muller et al., 1986). Serum was collected 8 to 10 days after the third, 
fourth and fifth injections. 
Translation in vitro. CPMV M RNA was translated in rabbit reticulocyte lysates (a generous gift from Dr R. J. 
Jackson) at 30 °C for 1 h as described by Pelham (1979). The I05K and 95K translation products were 
proteolytically processed into 58K, 48K and 60K proteins by the addition of 1 vol. of an S30 fraction from B RNA-
inoculated protoplasts as described by Franssen et al. (1982). 
Immunological methods. For immunoprecipitation, samples were either directly adjusted to I x RIA buffer (50 
mM-Tris-HCl pH 7-5, 150 mM-NaCl, 5 mM-EDTA, 1 % Triton X-100, 0 5% sodium deoxycholate, 01 % SDS), or 
first brought to 2% SDS, 5% 2-mercaptoethanol, boiled for 1 min, diluted at least I0:fold and then adjusted to 
t x RIA buffer. Immunoprecipitation was as described by Franssen et al. (1982). For protein blot analysis, 
fractions from cowpea protoplasts or leaves were separated in 12-5% SDS-polyacrylamide gels, blotted onto 
nitrocellulose filters and probed with anlisera (1500-fold dilution in RIA buffer) and ,2sl-labelled Protein A as 
described by Zabel el at. (1982). 
RESULTS 
Detection of a M r 60K precursor to the capsid proteins 
According to the translation model for M RNA in vitro (Fig. 1) the two capsid proteins VP37 
and VP23 are generated from a 60K precursor protein. To verify the existence of such a 
precursor in vivo, immunoprecipitations using anti-VP23 serum were carried out in extracts from 
CPMV-infectred [35S]methionine-labelled cowpea protoplasts. However, only mature VP23 
was detected in such extracts (Fig. 2, lane 3). In an attempt to accumulate possible precursor 
proteins by blocking or slowing down the proteolytic processing, CPMV-infected protoplasts 
were labelled in the presence of ZnCl 2 , since zinc ions are known to inhibit in vitro the 
processing of both the M RNA-encoded polyproteins (Pelham, 1979; Franssen el at., 1982) and 
theB RNA-encoded 170K protein (Peng &Shih, 1984). Sixteen h after inoculation, a solution of 
ZnCl , was added to infected protoplasts to a final concentration of 2 mM-Zn2+ arid 1 h later 
P sS)methionine (15 uCi/ml)
 uwas added. After a further 7 h (i.e. 24 h after inoculation) the 
protoplasts were collected by centrifugation and extracts were prepared for immunological 
analysis. In protoplasts incubated in the presence of ZnCl 2 , but not in untreated ones, a 60Iv 
protein was precipitated with anti-VP23 serum (Fig. 2, lanes 4 and 5). This protein comigrated 
with the 60K capsid precursor protein generated in vitro by processing of the translation 
products from M RNA in vitro with viral protease (Fig. 1) (Franssen el at., 1982). The 60K 
protein was also precipitatea with anli-VP37 serum (data not shown) and was only detectable in 
protoplasts inoculated with B .and M components and not in protoplasts inoculated with B 
component alone (Fig. 2, lanes 7 and 9). These data are consistent with the idea that the 60K 
protein delected m vivo contains the sequences of both M RNA-encoded capsid proteins and 
represents a precursor to these products. 
Detection of an M RNA-encoded 48K protein in infected protoplasts 
To enable the detection of M RNA-encoded 48K and/or 58K proteins in infected cells, 
antisera were prepared against two peptides corresponding to the theoretical carboxy-terminal 
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Fig. 1. Model for the e-xpression of CPMV M RNA. The long open reading frame of M RNA is 
indicated with an open bar on which the positions of the initiation codons used for translation are 
shown. The proteins are represented by single lines and the cleavage sites indicated by O. glutamine-
methionine and V» glutamine-glycine. 
Fig. 2. Detection of the 60K precursor to both capsid proteins in CPMV-infected protoplasts. 
Protoplasts inoculated with whole virus (lanes 2 to 5, 7 and 8) or B component alone (lanes 9 and 10) or 
mock-inoculated (lane 6) were labelled with [3sS]methionine in the presence (lanes 4, 5, 7 and 9) or 
absence (lanes 2, 3, 6, 8 and 10) of 2mM-ZnCl2. Immunoprecipitations were performed using 5ulanti-
VPg serum (lane 2, this serum also reacted with both capsid proteins, see Zabel et al., 1982) or 5 ui anti-
VP23 serum (lanes 4 to 10). The precipitates were analysed in a 12-5% Polyacrylamide gel and the 
proteins visualized by fluorography. Lane 1 shows the products of translation in vitro of CPMV M 
RNA. The immunoprecipitation with anti-VPg serum was performed to show the difference between 
the B RNA-encoded 60K. protein [(B)60K, VPg precursor] and the M RNA-encoded 60K capsid 
protein precursor. 
amino acid sequence of these proteins, as deduced from the M RNA nucleotide sequence (Van 
Wezenbeek et al., 1983). The primary structure of the peptides S and L is schematically shown in 
Fig. 3. The reactivity of the antisera obtained after the fourth injection was tested by 
immunoprecipitation of the products of M RNA translation in vitro. Both antisera appeared to 
be able to recognize the 58K. and 48K proteins as well as the 105K. and 95K. primary translation 
products (Fig. 4, lanes 1 and 2). The binding to the latter products was less pronounced probably 
because the antibodies bind to an internal region of these proteins. Preimmune sera did not react 
with any of the translation products of M RNA (data not shown). After verification of their 
reactivity and specificity, the two antisera were used to investigate the possible occurrence of M 
RNA-encoded 48K and 58K proteins in infected cells. 
At first, antibodies against peptide S were used to detect these proteins. Two identical protein 
blots were prepared containing both cytoplasmic (S30) and pellet fractions from protoplasts 
inoculated with whole virus or with B component alone and from uninoculated protoplasts. The 
antiserum appeared to react with various proteins, mainly present in the cytoplasmic fraction 
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Fig. 3. Structure of the synthetic peptides and their position in the M RNA-encoded proteins. The 
primary structure of the peptides is shown using the single letter code for amino acids. Prolines, thought 
to make a large contribution to the structure of the peptides, are underlined. The alanine at the carboxy 
terminus of peptide S is in parentheses since it is not present at the putative carboxy-lermini of the 48K 
and 58K proteins. V, glutamine-glycine; T , glutamine-methionine. 
(Fig. 5, lanes 10 to 15). The reaction with a number of these proteins was non-specific as these 
proteins also reacted with antiserum pretreated with excess ( 100 ng) peptide S (Fig. 5, lanes 2 to 
7). Further inspection of these blots revealed a protein reacting specifically with anti-peptides S 
serum and comigrating with the 48K product produced in vitro by M R N A (compare lanes 7, 15 
and 16 in Fig. 5). This48K protein was only found in the pellet fraction of protoplasts inoculated 
with whole virus and was missing in a similar fraction from protoplasts inoculated with the B 
component alone (Fig. 5, lane 14). Furthermore a 90K protein, present in low amounts in the 
same fraction as the 48K protein, reacted specifically with the antiserum. Surprisingly, three B 
RNA-encoded proteins (170K, U0K and 87K) present in the cytoplasmic fraction also 
appeared to react specifically with the anti-peptides S serum (Fig. 5, lanes 3 and 11) although 
there is no amino acid homology between these proteins and the peptide used to prepare the 
antiserum. 
The association of the 48K protein with the pellet fraction was rather strong as it was not 
possible tosolubilize this protein by treatment of the pellet fraction with 1 % Triton X-100 (data 
not shown). Since one of the plant proteins that reacted non-specifically with the anti-peptide S 
serum had a size of approximately 60K (see Fig. 5) it was not possible to determine whether an 
M RNA-encoded 58K. protein as predicted by the model of translation in vitro (Fig. 1) was 
present in CPMV-infected protoplasts as well. However, with the antiserum raised against 
peptide L, which did not show the non-specific reaction with a 60K plant protein, only a 48K 
protein could be detected in the pellet fraction of CMPV-infected protoplasts (see Fig. 6). Again 
a 90K protein also reacted with this antiserum (Fig. 6, lane 1). The anti-peptide L serum did not 
react with the B RNA-encoded proteins (data not shown). 
Detection of the 48 K protein in the membrane fraction of CPMV-infected cowpea leaves 
Infected cowpea leaves were also tested for the presence of 48K and 58K. proteins.CMPV-
infected and uninfected leaves were fractionated into cytoplasmic and membrane fractions 
(Zabel et al., 1982) which were incubal 'd with anti-peptide L serum. The immunoprecipitates 
were separated in a 12-5% SDS-polyacrylamide gel and subsequently blotted onto nitrocellulose 
filters. When the blot was treated with anti-peptide L serum and ' 25I-labelled Protein A (Fig. 7) 
a 48K protein was detected in the membrane fraction of infected leaves in agreement with the 
results obtained with protoplasts, but the 58K. protein was again not found (Fig. 7, lanes 4 and 5). 
Proteins of about 90K and 130K, present in the same fractions as the 48 K. protein, also appeared 
to react with this antiserum. Neither the 48K. nor the 58K protein could be detected in low-speed 
pellet fractions (nuclear fraction) or cell wall fractions prepared as described by Godefroy-
Colburn et al. (1986) of infected leaves (data not shown). 
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Possible excretion of the 4HK prolein front cowpea protoplasts 
Il has been suggested lhat the 48K protein may have a function in the cell-to-cell transport of 
virus (or viral RNA) in cowpea leaves (Rezelman et al., 1982). Therefore we examined whether 
this protein was excreted by infected protoplasts. Considerable amounts of the 48K protein 
could indeed be precipitated by anti-peptide L serum from the culture medium (Fig. 8, lane 3). 
Some larger products of about 90K and 130K were also detected in this medium. To test for 
proteins in the medium originating from damaged protoplasts, the culture medium was tested 
for the presence of other viral proteins. No proteins were detected using the anti-24K serum 
which specifically reacts with B RNA-encoded 170K, 110K, 84K and 24K proteins (Wellink et 
al., 1987) (Fig. 8, lanes 4 and 5). It is possible that the 48K protein was much more stable in 
medium than other viral proteins, but it appears more plausible that the 48K protein was 
specifically excreted by the protoplasts into the medium. 
DISCUSSION 
Of the two RNAs that make up the genome of CPMV, the expression of B RNA has been 
extensively studied in vivo as well as in vitro (Goldbach & Van Kammen, 1985). Analyses of the 
translation in vivo of M RNA have been hampered because the only M RNA-specified products 
found in vivo were the two mature capsid proteins VP37 and VP23. As a result the expression of 
M RNA has almost exclusively been studied'in translation systems in vitro. The in vitro data (Fig. 
1) have now gained substantial support by the detection in infected cells of a CPMV M RNA-
encoded 48K protein and a 60K precursor to both capsid proteins similar to the proteins 
produced in vitro by proteolytic processing of the M RNA-encoded 95K primary translation 
product. 
The 60K precursor was only detectable in CPMV-infected cowpea protoplasts when they 
were incubated in the presence of 2 mM-ZnCU. It is possible that normally the 60K capsid 
precursor is rapidly cleaved in vivo into the mature capsid proteins VP23 and VP37, while in the 
presence of Zn2+ ions the protease (or alternatively the production of the protease) responsible 
for this cleavage is inhibited, thus causing the accumulation of the unstable precursor. Zn2+ ions 
are indeed known to interfere with the processing of the CPMV polyproteins by inhibiting the 
cleavage of the B RNA-encoded 170K precursor into 110K and 60K proteins (Peng & Shih, 
1984; J. Wellink, unpublished results) as well as the cleavage of the M RNA-encoded 
polyproteins in vitro (Pelham, 1979; Franssen et al., 1982). 
Two initiation sites are used during the translation of M RNA in vitro resulting in primary 
translation products of 105K and 95K (Pelham, 1979; Franssen et al., 1982; Vos et at., 1984). 
These proteins are cleaved by a B RNA-encoded protease into 58K and 48K proteins together 
with the 60K capsid precursor protein discussed above (see Fig. 1 ; Pelham, 1979; Franssen et 
al., 1982, 1984). By employing antibodies raised against synthetic peptides the 48K but not the 
58K protein has now been detected in infected cowpea leaves and protoplasts. Since the 58K 
and 48K protein have identical carboxy termini it is not very likely that only the carboxy 
terminus of the 58K protein is processed (this would make it impossible for our antisera to react 
with this protein). Therefore such hypothetical modification does not provide the reason for our 
failure to detect this protein in infected cells. This raises the question whether the AUG codon at 
position 161 at the beginning of the long open reading frame of M RNA is actually used for 
translation in vivo. When M RNA is translated in vitro, the 95K protein is always produced in 
greater quantities than the 1Û5K protein, thus indicating that, in vitro, there is a preference for 
the internal initiation codons (at positions 512 and/or 524) over the 5' proximal A UG at position 
161. Both internal initiation codons indeed conform better to the Kozak rule (Kozak, 1984; Van 
Wezenbeek et al., 1983). It is therefore possible that in vivo the AUG codon at position 161 is 
rarely or never used. Alternatively the 105K and 95K proteins may be produced in more or less 
the same proportion as in vitro, but upon processing the 58K protein is rapidly degraded, 
whereas the 48K protein is accumulated. This idea is supported by the amino-terminal rule 
described by Bachmair et al. (1986), if one assumes that the amino-terminal methionine, coded 
for by the initiation codon, is removed from the 58K and 48K proteins [as is the case with the 
amino-terminal methionine of the CPMV B RNA-encoded 200K polyprotein (Wellink et ai, 
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1986)]. This would result in a 58K. protein with an amino-terminal phenylalanine (predicted to 
be unstable; Bachmairef a/., 1986) and a48K protein with an amino-terminal serine (predicted 
to be stable. Bachmaireru/. , 1986) when the A U G codon at position 524 is used as the initiation 
codon. Since all comoviruses tested so far produce two polyproteins upon translation in vitro of 
their M RN As (Goldbach & Krijt, 1982), it is possible that they all follow this strategy. This idea 
is further supported by the sequence of the M RNA of red clover mottle virus (RCMV), another 
comovirus (Shanks et al., 1986). A considerable amount of amino acid homology was detected 
between the proteins encoded by the M RNAs of CPMV and RCMV, except for the region 
coding for the amino terminus of the CPMV 105K protein. In fact, the homology with the 
RCMV proteins starts just behind the AUG codon of the 95K protein (Shanks et ai, 1986). Also 
for RCMV, the amino-terminal rule predicts an unstable 58K protein and a stable 48K protein. 
But why do comoviruses use two initiation sites on their M RNA resulting in a stable and an 
unstable protein with partially overlapping sequences? It may be possible that by the use of 
several initiation sites, the M RNA of these viruses is translated more efficiently, thus producing 
the large amounts of capsid proteins needed to encapsidate the viral RNA. 
A 95K primary translation product has not been delected in cowpea leaves or in protoplasts, 
either with antisera against the capsid proteins or with antisera against the synthetic peptides, 
presumably because it is rapidly cleaved into the 48K protein and the 60K capsid precursor. In 
fractions that contained the 48K protein, proteins of 90K and 130K were also found to react 
specifically with the anti-peptide L serum. Although their origin is unknown, their sizes suggest 
that they are dimers and trimers of the 48K protein. 
The 48K protein was detected by antisera directed against both peptide S and peptide L. Both 
antisera reacted non-specifically with several plant-encoded proteins. The anti-peptide S serum 
also reacted specifically with three CPMV B RNA-encoded proteins, but at the moment we 
cannot explain this reaction. 
The48K protein was found to be present in the membrane fraction of both infected leaves and 
protoplasts. The association with membranes was strong since treatment of the membranes with 
\% Triton X-100 did not solubilize the protein. Additionally the 48K protein and its 
presumptive multimers were detected in medium in which infected protoplasts had been 
cultured, whereas no other non-structural proteins could be detected in this medium. The 
presence of free 48K protein seems not to be due simply to leakage or damaged protoplasts, but 
may be the result of specific excretion. It has been suggested that the 48K protein is involved in 
transport of virus particles or RNA throughout leaves (Rezelman et al., 1982). The presence of 
this protein in membranes of infected cells as well as in culture medium is consistent with this 
idea. Furthermore the 48K. protein shows limited homology to the 30K protein of tobacco 
mosaic virus (Meyer et al., 1986) which is thought to be involved in cell-to-cell transport 
(Leonard & Zaitlin, 1982; Ohno et al., 1983; Zimmern & Hunter, 1983). 
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was supported by the Netherlands Foundation for Chemical Research (S.O.N.) with financial aid from the 
Netherlands Organization for the advancement of Pure Research (Z.W.O.). M.J. was the recipient of a fellowship 
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SUMMARY 
Infection of cowpea (Vigna unguiculata) cells with cowpea mosaic virus (CPMV) 
is accompanied by the appearance of characteristic cytophatic structures. A major 
constituent of these cytophatic structures represented by the electron-dense 
material, was shown to contain viral non-structural proteins by an immunocytochemical 
technique using colloidal gold labelled protein A as a marker. With this same technique 
virus particles were found to accumulate mainly in the cytoplasm. 
The genome of cowpea mosaic virus (CPMV) consists of two positive strand RNAs which are 
separately encapsidated in identical protein shells. Both RNAs (denoted B and M RNA) have 
a small protein (VPg) linked a t their 5' end, are polyadenylated and possess a single long 
open reading frame (for a recent review see Goldbach and Van Kammen, 1985). Figure 1 
schematically shows how the large polyproteins encoded by these RNAs are processed into 
functional polypeptides. Infection with CPMV is accompanied by the appearance of 
characteristic cytopathic structures (Assink et al., 1973; De Zoeten et al., 1974). These 
structures consist of amorphous electron-dense material and numerous membranous vesicles. 
Autoradiography performed on sections of isolated cytophatic structures treated with [3H] 
uridine provided evidence that the replication of the CPMV RNAs was associated with these 
vesicles (De Zoeten et al., 1974), but the nature of the electrondense material has remained 
unknown. 
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Fig. 1. Model for the expression of the CPMV RNAs. The open reading frames in both RNAs are 
indicated by white bars. Proteins are represented as single lines and VPg as a black square. The 
positions of the translatlonal start and stop codons are indicated. 
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In CPMV infected cells large amounts of virus particles are produced (up to 1 mg per g 
leaves). Besides, most of the non-structural proteins are also easily detectable in infected 
protoplasts by labelling with P 5 s ] methionine (Rezelman et al., 1980). In an effort to 
localize sites within the infected cell where these structural and non-structural viral 
proteins accumulate we used an immunocytochemical technique based on colloidal gold 
labelled protein A. 
Preparation of protein A-gold complexes with gold particle diameter of 7 run and 
immunogold labelling were as described by Van Lent and Verduin (1986). The antisera used 
for the experiments described in this paper have been characterized for their reactivity 
with CPMV specific proteins presented on protein blots. The anti-24K serum recognized the 
24K protein and all proteins containing the 24K sequence namely 170K, 110K and 84K 
proteins (fig. 1; Wellink et al., 1987). Anti-170K serum recognized the 170K, 110K and 87K 
proteins (Dorssers et §1., 1984). Anti-VPg serum, obtained after Injection of a rabbit with 
synthetic VPg (Jaegle et §1., 1987), reacted with 170K, 84K and 60K proteins on a protein 
blot (J. Wellink, unpublished results). The anti-CPMV serum was obtained by injecting a 
rabbit with purified CPMV components. Gamma globulins (IgG) were purified from the antisera 
by affinity-chromatography on columns of sepharose CL-4B-protein A. 
Cowpea mesophyll protoplasts were isolated, inoculated with CPMV components or RNA and 
cultured under continuous light as described by Rezelman et al. (1980) and Maule et al. 
(1980). At different times after inoculation (t = 0, 12, 24 and 48 h) samples of these cells 
were fixed, dehydrated and embedded at low teperature in lowicryl K4M as described by Van 
Lent and Verduin (1986). 
The sections of embedded protoplasts showed that cell organization and organelles were 
preserved, however, preservation of membranes was poor due to extraction during the 
embedding procedure. Infection of protoplasts was f i rs t recognized at t = 12 h after 
inoculation by the presence of electron-dense material in the cytoplasm. No vesicles were 
found a t this time. At t = 24 and 48 h cytopathic structures had developed consisting of 
electron-dense material and an increasing number of vesicles. Similar results were reported 
by Rezelman et al. (1982). 
In sections of protoplasts, isolated at t = 12, 24 and 48 h after inoculation and treated 
with anti-24K IgG and protein A-gold, gold label was exclusively located on the electron-
dense material of the cytopathic complex (see Fig. 2). Similar results were obtained with 
anti-VPg serum (data not shown) and anti-170K serum (Fig. 3). No gold label could be 
detected in or near the vesicles of the cytopathic complex, the cytoplasm and cell 
organelles when antisera against the non-structural proteins were used (Fig. 2,3). However, 
with anti-CPMV IgG and protein A-gold, label was found throughout the cytoplasm of 
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Fig. 2. Section of cowpea mesophyll protoplasts, isolated 48 h after inoculation with CPMV RNA, and 
incubated with anti-24K IgG and protein A-gold. Gold label (black dots) is mainly present over the 
electron-dense material (ED); C, chloroplast; V, vacuole. Bar marker represents 200 run. 
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Fig. 3. Section of cowpea mesophyll protoplast, isolated 48 h after inoculation with CPMV, and 
incubated with anti-170K IgG and protein A-gold. Gold label is mainly present over the electron-
dense material (ED) but not over and between the vesicles (Vs). C, chloroplast; V, vacuole. Bar 
marker represents 400 not. 
73 
Fig. 4. Section of cowpea mesophyll protoplast, isolated 48 h after inoculation with CPMV RNA, and 
incubated with anti-CPMV IgG and protein A-gold. Gold label is present over the cytoplasm and 
between the vesicles (Vs) but i s almost absent over the electron-dense material (ED); N, nucleus. 
Bar marker represents 200 nm. 
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protoplasts isolated 48 h after inoculation (Fig. 4). Similar occurrence of virus particles 
was reported for another comovirus, red clover mottle virus, in pea leaf cells (Tomenius et 
al., 1983). 
The results obtained with the antisera against the 24K and 170K proteins and VPg show 
that the electron-dense material from the CPMV-induced cytopathic structure contains CPMV 
B RNA-encoded non-structural proteins. So far we have not been able to determine whether 
all B RNA-encoded proteins are present in this structure, since the three antisera used 
for these experiments each react with a set of overlapping proteins (Fig. 1). The vesicles 
that are also present in the cytopathic structure have been implicated in viral RNA 
replication (De Zoeten et al., 1974), but i t remains to be established whether the electron 
dense material also fulfils a function in this process. It has been proposed that the viral 
proteins active in the replication of the CPMV RNAs are only able to synthesize one RNA 
strand (Van Kammen and Eggen, 1986). It is therefore possible that these used up proteins 
accumulate in the electron-dense material. 
The authors thank Gré Heltkönig for typing of the manuscript. This work was financially 
supported by a grant from the Netherlands Organisation for Biological Research (BION) to 
J.v.L. 
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CHAPTER 8 
SUMMARY AND CONCLUSIONS 
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In our study on the proteolytic processing of the 200K polyprotein encoded by 
CPMV B-RNA we first examined the types of cleavage sites present in this 
polyprotein. Previously Zabel et al. (1984) had shown that VPg is released from 
i t s 60K precursor by cleavage between a glutamine-serine dipeptide sequence, and 
the question was whether all cleavages in the 200K polyprotein occurred at 
glutamine-serine sites or not. The determination of partial amino acid sequences 
of isolated B-RNA-encoded proteins and alignment of these sequences with the 
open reading frame in B-RNA revealed that three types of cleavage sites are used 
to process the 200K polyprotein namely glutamine-serine (2x), glutamine-glycine 
and glutamine-methionine amino acid pairs (Chapter 3). A glutamine-methionine 
and glutamine-glycine site are also present in the M-RNA-encoded polyprotein, as 
revealed by partial amino acid sequencing of the capsid proteins (Franssen et 
al., 1986). A common feature of the sequences surrounding the different cleavage 
sites is that they have alanine at position -4 and alanine or proline at posi-
tion -2, but beyond that there is no obvious homology among the cleavage sites. 
Since there occur several glutamine-glycine, glutamine-serine and glutamine-
methionine dipeptide sequences in the polyproteins which are not cleaved, pro-
bably the secondary and ter t iary structure of the polypeptide chains are also 
important factors in determining the cleavage sites involved in the processing. 
The processing model of the 200K polyprotein, based on analysis of B-RNA-encoded 
proteins found in vivo and in vitro translation studies, postulated the for-
mation of a 24K protein as a final cleavage product (Rezelman et al., 1980; 
Franssen et al., 1984a). To demonstrate the actual presence of such protein in 
infected cells we have used antibodies raised against a synthetic peptide with 
an amino acid sequence corresponding to part of this hypothetical protein. The 
antibodies indeed reacted with a 24K protein in CPMV infected protoplasts and 
also with the 84K, 110K and 170K precursors which contain- the sequence of the 
24K protein (Chapter 4). In view of the results of processing of the in vitro 
translation products of B-RNA and i t s homology to the Picornavirus encoded pro-
teases i t was previously suggested that the 24K protein possesses proteolytic 
activity. The protease activity of the 24K protein, was examined by expressing a 
hybrid cDNA construct, containing the 24K coding region linked to the coding 
region of both capsid proteins, in E. coli using the T7 promoter/polymerase 
system of Tabor and Richardson (1985) (Chapter 5). This resulted in the produc-
tion of several virus-specific proteins which were characterized using specific 
antibodies. Pulse-chase experiments showed that two primary products were pro-
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duced (the smaller one was probably the result of internal initiation of 
translation) which underwent faithful cleavage at two glutamine-glycine sites. 
One of the cleavage products represented the small capsid protein VP23. When a 
construct was used in which the 24K coding sequence contained a small deletion 
only two large proteins could be detected. These results unequivocally indicate 
that the 24K protein catalyzes the cleavages at the glutamine-glycine sites in 
the CPMV polyproteins (Chapter 5). 
Recent experiments described by Verver et al. (1987) have shown that the 24K 
protein (or proteins containing the 24K sequence) is also able to cleave one of 
the glutamine -serine sites in the 200K polyprotein. Furthermore, Franssen et al. 
(1984b) had obtained evidence that the B-RNA-encoded 32K protein was involved in 
the cleavage at the glutamine-methionine si te in the M-RNA-encoded polyprotein. 
Therefore i t was proposed that the 24K protein is probably catalyzing the 
cleavages at all glutamine-serine and glutamine-glycine sites, while on the 
other hand the 32K protein would be involved in the cleavage of both glutamine-
methionine si tes in the CPMV polyproteins. Indeed, serine and glycine are simi-
lar amino acids with respect to their side groups (small polar) whereas 
methionine is very different (large non-polar side group), further supporting 
the idea that two different proteases would be necessary to cleave all cleavage 
sites. However, recently Vos et al. (1987a) have definitely shown that the 24K 
protein is able to catalyze all cleavages in the CPMV polyproteins but that for 
the cleavage of the glutamine-methionine si te in the M-polyprotein the 32K pro-
tein is essential as a cofactor (see Vos et al., 1987a). 
Another question we have addressed in our study on the expression of the CPMV 
RNAs is the expression of M-RNA in vivo. In vitro, M-RNA is translated into two 
carboxy-terminal overlapping polyproteins (105K and 95K) the smaller one as a 
result of initiation at an internal AUG codon (Vos et al., 1984). These proteins 
are cleaved by a B-RNA-encoded activity into 58K and 48K proteins and a 60K cap-
sid protein precursor (Franssen et §1., 1982). At the other hand in 
CPMV-infected cells the two capsid proteins VP23 and VP37 are the only 
M-RNA-encoded proteins readily detectable. To elucidate the expression mechanism 
of M-RNA in vivo we have searched for the 60K capsid precursor and for the 58K 
and 48K proteins in CPMV-infected cells. Using antibodies against the capsid 
proteins and ZnCl2 the 60K capsid precursor protein was detected in 
CPMV-inoculated protoplasts incubated in the presence of ZnCl2 (Chapter 6). Zn++ 
ions are known to inhibit the proteolytic processing of several viral polypro-
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teins eind probably this has caused the 60K protein to accumulate in these 
cells. 
Using antibodies against synthetic peptides, corresponding to the common 
carboxy-terminus of the 48K and 58K proteins, a 48K protein was detected in the 
membrane fractions of infected cells. A viral 58K protein could not be detected 
(Chapter 6). The presence of the 48K and 60K proteins in infected cells links 
the in vitro translation results with the in vivo situation and shows that also 
in vivo CPMV M-RNA is expressed via proteolytic processing of a polyprotein. As 
sofar direct evidence for the occurrence of a M-RNA-encoded 58K polypeptide in 
vivo is lacking i t remains unknown whether in vivo M-RNA, besides being 
translated into a 95K polypeptide start ing a t the initiation codon at position 
524, is also expressed by translation, start ing at the AUG codon at position 
161, into a 105K polypeptide. In vitro the 105K protein is usually produced in 
considerable smaller amounts than the 95K protein and i t seems plausible that 
this also occurs in vivo and perhaps the amount of 58K protein is very low and 
remains below the present level of detection. Another possibility is that the 
58K protein is unstable and rapidly degraded in infected cells. It is a striking 
fact that the M-RNAs of all comoviruses studied sofar produce two polyproteins 
upon in vitro translation (Goldbach and Krijt, 1982), supporting the idea that 
the presence of two AUG initiation codons in the same reading frame has some 
functional significance. In our opinion i t seems therefore likely that in vivo 
some 58K protein will be produced. 
Previously i t was suggested that the M-RNA-encoded 48K (and 58K) protein has a 
function in cell to cell transport of the virus (Rezelman et al., 1982). We have 
now shown that the 48K protein is present in the membrane fraction of infected 
cells and is excreted in the incubation medium of CPMV infected protoplasts 
(Chapter 6). These findings are consistent with a possible function of the 48K 
protein in virus transport. 
Infection of cells with CPMV is accompanied with the production of membranous 
vesicles and electron-dense amorphous material. We have demonstrated that the 
electron-dense material contains (if not represents) non-structural 
B-RNA-encoded proteins. This was established by immunocytochemical labeling of 
sections of CPMV infected protoplasts with specific antibodies and protein A-
gold (Chapter 7). The data collected correlate well with the observation that 
during a CPMV infection a considerable amount of non-structural proteins is pro-
duced (Goldbach and Van Kammen, 1985). Apparently these proteins are located in 
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the cytophatic structure as a part of the electron-dense material. The membra-
nous vesicles have been implicated with viral RNA replication (De Zoeten et al., 
1974) but the question whether the electron-dense material also has a function 
in virus multiplication remains to be answered. 
With the detection of the 60K, 48K and 24K proteins in infected cells probably 
all major proteins expressed from the CPMV RNAs have now been identified. It is 
also clear now that all these proteins are produced by proteolytic processing of 
two polyproteins between three different pairs of amino acids and that the 24K 
protein is the protease catalyzing these cleavages. Future research will con-
centrate on the functions of these proteins. The synthesis of infectious 
transcripts from complete cDNA clones of both M- and B-RNA as recently described 
by Vos et al. (1987) opens the way to introduce specific mutations in the RNAs 
and this will, together with the techniques which have been described in this 
thesis, form the basis for further research on the elucidation of the replica-
tion mechanism of CPMV and i t s pathogenic action in the host plant. 
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CHAPTER 9 
SAMENVATTING 
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Cowpea mozaïek virus (CPMV) is een virus dat als voornaamste gastheer de cowpea 
boon (Vigna unguiculata L., in Nederland beter bekend als kouseband) infecteert. 
De symptomen die op een cowpea plant ontstaan door een infectie met dit virus 
kunnen afhankelijk van de virusstam variëren van mild mozaïek, hevig mozaïek en 
bladvervorming tot afstérvingsverschijnselen. Het genoom van het virus bestaat 
uit twee lange RNA moleculen die in een cel direct als boodschapper RNA kunnen 
dienen. De RNA's zijn elk afzonderlijk verpakt in identieke eiwitmantels en vor-
men aldus de zg. Bodem (B) en Midden (M) component. Hoewel beide deeltjes nood-
zakelijk zijn om planten succesvol te infecteren, kan het RNA uit de B component 
(B-RNA) zich zelfstandig vermenigvuldigen in geïsoleerde cowpea bladcellen 
(protoplasten). De RNA's bezitten ieder een klein eiwit (VPg) aan het 5' 
uiteinde, een poly A staart aan het 3' uiteinde, en één enkel open leesraam 
waaruit zg. poly-eiwitten vertaald worden. Deze poly-eiwitten worden direct, of 
zelfs tijdens hun synthese door proteolytische klievingen in verscheidene func-
tionele eiwitten geknipt. 
Eén van de voornaamste doelen van het in dit proefschrift beschreven onderzoek 
was meer inzicht te krijgen in het proces van deze proteolytische klievingen. 
Hierbij ging de meeste aandacht uit naar het 200K poly-eiwit dat door het B-RNA 
gecodeerd wordt. Als een eerste stap is uitgezocht welke klievingsplaatsen 
gebruikt worden in dit 200K eiwit. Door het bepalen van gedeeltelijke aminozuur-
volgorden van het amino-uiteinde van gezuiverde, door het B-RNA gecodeerde 
eiwitten, en het vergelijken ervan met de aminozuurvolgorde die afgeleid is van 
de nucleotidenvolgorde van het B-RNA, werd vastgesteld dat er 3 soorten 
klievingsplaatsen zijn in het 200K eiwit, namelijk tussen de aminozuurparen 
glutamine-serine (op twee plaatsen), glutamine-glycine en glutamine-methionine 
(hoofdstuk 3). Eerder was al vastgesteld dat glutamine-methionine en glutamine-
glycine klievingsplaatsen ook voorkomen in het poly-eiwit dat gecodeerd wordt 
door het M-RNA. 
Het klievingsmodel van het 200K eiwit, dat gebaseerd is op analyses van de door 
het B-RNA gecodeerde eiwitten, voorspelde dat er ook een 24K eiwit gevormd kon 
worden. Om het 24K eiwit aan te tonen in geïnfecteerde cellen, hebben we ant i -
lichamen opgewekt tegen een synthetisch peptide met een aminozuurvolgorde die 
overeenkomt met een deel van dit hypothetische 24K eiwit. Het voorkomen van het 
24K eiwit in CPMV-geïnfecteerde protoplasten kon daadwerkelijk vastgesteld wor-
den met dit antiserum. Het antiserum reageerde ook met de al langer bekende 84K, 
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HOK en 170K eiwitten die allen de 24K sequentie bevatten (hoofdstuk 4). 
Op grond van de resultaten van in vitro vertalingsexperimenten met B-RNA en op 
grond van de homologie die het 24K eiwit vertoont met een protease van picor-
navirussen, was het vermoeden gerezen dat dit 24K eiwit een protease is. De 
mogelijke proteolytische act ivi tei t ervan werd onderzocht door een cDNA 
fragment, coderend voor dit eiwit, te koppelen aan een cDNA fragment dat 
codeerde voor de beide manteleiwitten en dit geheel tot expressie te brengen in 
de bacterie Escherichia coli (hoofdstuk 5). Dit resulteerde in de aanmaak van 
een aantal virusspecifieke eiwitten die gekarakteriseerd werden met verschil-
lende antisera. Uit de resultaten van een "pulse-chase" experiment bleek 
dat er twee grote eiwitten werden gesynthetiseerd, waarvan het kleinste 
waarschijnlijk het resultaat van interne ini t iat ie was. Beide eiwitten bleken 
vervolgens op twee glutamine-glycine plaatsen gekliefd te worden in kleinere 
producten, waaronder het kleine manteleiwit VP23. In E. coli cellen die een 
vergelijkbaar construct met een deletie in de sequentie, die codeert voor het 
24K eiwit, bevatten werden alleen de twee grote virusspecifieke eiwitten gevormd 
en vonden geen verdere .klievingen plaats. Deze resultaten toonden aan dat het 
24K eiwit verantwoordelijk is voor beide glutamine-glycine klievingen. 
Tegelijkertijd werd in ons laboratorium aangetoond dat het 24K eiwit (of 24K 
bevattende eiwitten) ook verantwoordelijk is voor één van de glutamine-serine 
klievingen in het 200K eiwit. Verder zijn er al eerder proeven beschreven 
waaruit bleek dat het 32K eiwit, dat gecodeerd wordt door het B-RNA, betrokken 
is bij de klieving van een glutamine-methionine dipeptide sequentie in het poly-
eiwit dat gecodeerd wordt door het M-RNA. Al deze resultaten maakten het 
waarschijnlijk dat het 24K eiwit verantwoordelijk was voor alle glutamine-
glycine en glutamine-serine klievingen en het 32K eiwit voor de beide glutamine-
methionine klievingen. Omdat serine en glycine aminozuren zijn met een kleine 
polaire zijgroep terwijl methionine een grote apolaire zijgroep bezit, was het 
inderdaad niet onaannemelijk dat twee verschillende proteases betrokken zouden 
zijn bij de diverse klievingen. Deze aanvankelijke veronderstelling bleek echter 
een misvatting te zijn omdat later is aangetoond dat het 24K eiwit (en/of 24K 
bevattende eiwitten) verantwoordelijk is voor alle klievingen in de M- en B-
poly-eiwitten (P. Vos, J. Verver, M. Jaegle, J. Wellink, A. van Kammen en R. 
Goldbach, manuscript in voorbereiding). Alleen bij de glutamine-methionine 
klieving in het M-poly-eiwit is ook het 32K eiwit betrokken, echter niet als 
protease maar als cofactor. 
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Een ander interessant probleem bij de expressie van de CPMV-RNAs is de expressie 
van M-RNA in vivo. De nucleotidenvolgorde van het M-RNA bevat één lang open 
leesraam, maar in vitro wordt het M-RNA vertaald in twee eiwitten, van 105K en 
95K, die alleen verschillen in hun amino-terminale uiteinden. Het kleinste eiwit 
is het resultaat van ini t iat ie van de vertaling op een intern AUG codon. Beide 
eiwitten worden gekliefd in 58K en 48K eiwitten en een 60K precursor voor de 
beide manteleiwitten. In geïnfecteerde cellen zijn echter de beide manteleiwit-
ten de enig bekende eiwitten die door het M-RNA gecodeerd zijn. Dit heeft ons er 
toe gezet om op zoek te gaan naar de 60K, 58K en 48K eiwitten in geïnfecteerde 
cellen. Het bleek mogelijk om met behulp van antiserum tegen de manteleiwitten 
de 60K precursor voor de beide manteleiwitten ook in vivo te detecteren door de 
geïnfecteerde protoplasten te behandelden met ZnClg (hoofdstuk 6). Zink-ionen 
staan bekend als remmers van de klieving van virale poly-eiwitten en hierdoor 
kan de 60K precursor zich kennelijk ophopen. Door gebruik te maken van ant i -
lichamen gericht tegen synthetische peptiden, corresponderend met het gemeen-
schappelijke carboxyl-uiteinde van de 58K en 48K eiwitten, was het mogelijk het 
48K eiwit te detecteren in de membraanfractie van CPMV-geïnfecteerde cellen. Een 
58K eiwit werd niet aangetroffen. Met de detectie van de 48K en 60K eiwitten in 
de geïnfecteerde cel zijn nu de resultaten van de in vitro vertalings-experimen-
ten grotendeels in overeenstemming te brengen met waarnemingen in vivo en is 
aangetoond dat het CPMV M-RNA ook in de geïnfecteerde cel via proteolytische 
klievingen van een poly-eiwit tot expressie komt (hoofdstuk 6). 
Omdat tot nu toe het voorkomen van een door het M-RNA gecodeerd 58K eiwit in 
geïnfecteerde cellen niet aangetoond kan worden, is het nog steeds een open 
vraag of het M-RNA in vivo al dan niet vertaald wordt in een 105K eiwit. In in 
vitro vertalingen wordt meestal minder 105K dan 95K eiwit gemaakt en als dit 
ook in vivo het geval is dan zal dit product met deze methode niet detecteerbaar 
zijn. Het is daarnaast ook mogelijk dat het 58K eiwit minder stabiel is dan het 
48K eiwit en snel wordt afgebroken. Het is opvallend dat de M-RNA's van alle tot 
nu toe onderzochte comovirussen in vitro vertaald worden in twee poly-eiwitten. 
Dit is een aanwijzing dat het gebruik van twee startcodons in hetzelfde leesraam 
een functionele betekenis heeft en het is dan ook waarschijnlijk dat er in vivo 
58K eiwit wordt gemaakt. 
Uit eerdere experimenten is geconcludeerd dat de door het M-RNA gecodeerde 48K 
(en 58K) eiwit mogelijk een functie heeft bij het transport van het virus (of 
virale RNA) van cel naar cel. We hebben aangetoond dat het 48K eiwit voor-
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namelijk aangetroffen wordt in de membraanfractie van de geïnfecteerde cel en 
dat dit eiwit uitgescheiden wordt in het voedingsmedium van protoplasten ge-
ïnfecteerd met CPMV (hoofdstuk 6). Deze waarnemingen zijn in overeenstemming met 
het idee dat het 48K eiwit betrokken is met het transport van het virus. 
Verschillende virussen induceren zg. cytopathologische structuren in de cellen 
die ze hebben geïnfecteerd. Zo veroorzaakt een CPMV infectie de productie van 
vesiculaire membraanzakjes (vesicles) en electronendicht, amorf materiaal. De 
electronendichte structuren blijken nu niet-structurele door het B-RNA geco-
deerde eiwitten te bevatten. Dit is met behulp van elektronenmicroscopie 
vastgesteld door coupes van met CPMV geïnfecteerde protoplasten te incuberen met 
specifieke antilichamen en deze vervolgens te voorzien van goudbolletjes gekop-
peld aan proteïne A (hoofdstuk 7). Gedurende een CPMV infectie worden vrij grote 
hoeveelheden niet-structurele eiwitten geproduceerd en het is dus zeer goed 
mogelijk dat deze eiwitten zich ophopen in deze electronendichte structuren. 
Verder onderzoek is nodig om te bepalen of deze electronendichte structuren een 
functie hebben in de virusvermenigvuldiging, of dat deze structuren het gevolg 
zijn van ophopen van "verbruikte" en/of niet-functionele virale eiwitten. 
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